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ABSTRACT
Osteoporosis is a serious health issue affecting 10 million Americans, with an
additional 44 million being at risk. Due to the morbidity and mortality associated with
fractures caused by osteoporosis, it is an important public health concern. Some
researchers suggest that African-American women fracture at a lower rate when
compared to Caucasians with the same bone mineral density (BMD). However, when
African-American women do fracture, they have higher mortality and morbidity rates.
Data regarding risk factors and prevalence of low BMD among African American and
Caucasian college-aged women are limited. Purpose: The primary purpose of this
research was to explain the variance in bone mineral density (BMD) in African-American
and Caucasian college-aged women. A secondary purpose was to evaluate the
differences in osteoporosis knowledge among college-aged African-American and
Caucasian women. Methodology: This study included 101 women ages 18 to 30
years. Fifty participants were African-American and 51 were Caucasian.
Anthropometric measurements, osteoporosis knowledge, bone mineral density, body
composition, physical activity and nutrient intake were assessed in the present study.
Results: In this sample, 38.6% had low spinal BMD and 7.9% had low femoral bone
mineral density. Femoral and spinal BMD were regressed on seven potential
predictors: race, family history of osteoporosis, weight, current physical activity,
osteoporosis knowledge, length of time on oral contraceptives, and calcium intake.
Multiple regression analysis showed that BMI/weight and current physical activity were
ii

the only two independent variables that significantly predicted spinal and femoral BMD.
The final model explained 14.9% of the variance in spinal BMD and 13.1% of the
variance in femoral BMD. Osteoporosis knowledge was not significantly different
between African-Americans and Caucasians. Conclusions: Contrary to what was
hypothesized, race was not a significant predictor of spinal or femoral BMD. Therefore,
it is important for both African-American and Caucasian women alike to engage in
osteoporosis-preventive behaviors. If women between the ages of 18 and 30 are made
aware of their low-BMD status, they can begin bone-building activities before they reach
peak bone mass. This provides an opportunity to decrease risk for osteoporosis and
related fractures later in life.
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Chapter I
Introduction
Osteoporosis is defined as a skeletal disorder characterized by compromised
bone strength, predisposing a person to an increased fracture risk (National Institutes of
Health, 2001). The term “osteoporosis,” which literally means “porous bone,” was
coined by French pathologist Jean Georges Chretien Frederic Martin Lobstein in the
1830s to describe patients’ bones that had larger than normal holes (Patlak, 2001).
Osteoporosis was not officially recognized as a disease by the World Health
Organization (WHO) until 1994--over a century after it was first described (Anderson
and Delmas, 2002).
It is estimated that 10 million Americans have osteoporosis, while 44 million
adults over the age of 50 years are estimated to be at risk for this disease (Thomas,
2007). It is projected that by the year 2020, osteoporosis will affect approximately 14
million adults over the age of 50 (Lane, 2006). Women account for 80% of those
affected by osteoporosis; and, men account for the remaining 20% (National
Osteoporosis Foundation [NOF], 2008). As a result of the higher prevalence of
osteoporosis in women, their risk of hip fractures is equal to their risk of breast, uterine,
and ovarian cancers combined (Thomas, 2007).
Due to the morbidity and mortality associated with fractures caused by
osteoporosis, it is an important public health concern (Thomas, 2007). The
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annual incidence of osteoporotic fractures is estimated at over 1.5 million in the United
States with 1 in 5 persons dying during the first year following a hip fracture (Lane,
2006). Some factors associated with increased mortality following a hip fracture include
preexisting chronic conditions and low physical ability in patients prior to hip fracture
(Meyer, Tverdal, Falch, and Peders, 2000). Hip fractures are considered the most
serious kind of fracture due to the cost, mortality, and morbidity associated with them
(Cummings and Melton, 2002). In 2005, hip fractures accounted for 72% of the
estimated $17 billion spent on osteoporotic fractures in the United States (Burge et al.,
2007). The medical cost of osteoporosis-related fractures is projected to rise nearly
50% by the year 2025 (Burge et al., 2007). Fifty to 70% of older patients are not able to
return to their prefracture level of functioning; and, up to 79% of older patients are
unable to ambulate following a hip fracture (Coleman et al., 2000).
When examining the mortality and morbidity statistics associated with
osteoporotic fractures, studies show that certain ethnic groups are affected
disproportionally. Barrett-Connor et al. (2005) suggest that Black women fracture at a
lower rate when compared to Caucasians with the same bone mineral density; but,
when they do fracture they have higher mortality and morbidity rates. These differences
in outcome, in part, can be attributed to racial disparities in screening and treatment of
Blacks at risk for osteoporosis. Neuner et al. (2007) found that Black female Medicare
recipients aged 65-89 years, who resided in Florida, Illinois, or New York, were about
2/3 less likely than Whites to undergo BMD testing. Moreover, after surveying Black
and White women aged 50 years and older who received their health care coverage
through a large regional managed care organization in Alabama, Mudano et al. (2003)
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found that Black women had roughly a two-third lower odds than White women of
receiving BMD testing and all forms of prescription osteoporosis, even after having a
previous fracture. Miller et al. (2005) found that the odds of at-risk Black women being
referred for bone density testing were 61% lower than that of White women of
comparable risk. Physicians were also less likely to recommend calcium and vitamin D
supplementation to at-risk Blacks in comparison to White women of comparable risk
(Miller et al., 2005).
The number of osteoporotic fractures is projected to increase an estimated 2.5
million by the year 2025 with African American women accounting for 3.2 % of the
increase (Vanness and Tosteson, 2005). This is mainly due to the growing elderly
population in the United States. By the year 2030 in the United States, ethnic minorities
will comprise 25% of the 65 and older population (Bohannon, 1999). Annually, about
500,000 hospitalizations, 800,000 emergency room visits, and 180,000 nursing home
placement can be attributed to osteoporotic fractures (US Department of Health and
Human Services [USDHHS], 2004).

BMD and Fracture Risk
There is a strong relationship between BMD and fracture risk in postmenopausal
women. In postmenopausal White women, there is a 1.5 to 2.6-fold increase in relative
fracture risk for every one standard deviation decrease in BMD (Siris et al., 2001).
However, this relationship is unclear in premenopausal women (Gourlay and Brown,
2004). Furthermore, there are limited data on the relationship between BMD and
fracture risk in non-Caucasian women. Moreover, the data that exists are difficult to
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interpret (Binkley, Schmeer, Wasnich, Lenchik, 2002). Some researchers recommend
not using the word “osteoporosis” in conjunction with premenopausal women in cases
where the diagnosis is based solely on BMD, when values are at the low end or just
below normal BMD values, and when no fractures have occurred in the past (Cohen
and Shane, 2008). The International Society for Clinical Densitometry (ISCD) goes
even farther and states that the WHO classification for normal, osteopenia, and
osteoporosis is not appropriate for healthy premenopausal women (Lewiecki, 2005).
Below normal BMD values in young adults are typically not an important concern due to
their low risk of falls and their greater muscle strength and agility (Gourlay and Brown,
2004). However, a history of premenopausal fractures increases risk of
postmenopausal fractures (Hosmer, Genant, and Browner, 2002). Bone mineral density
acquired by early adulthood can explain 60% of osteoporosis risk (Bachrach, Hastie,
Wang, Narasimhan, and Marcus, 1999). Therefore, attainment of high peak bone mass
can greatly reduce osteoporosis and associated fracture risk.

T-score and Z-score
The skeleton consists of cortical bone and trabecular bone. Cortical bone, which
forms the outer part of long bones, is very dense and calcified, whereas trabecular
bone, located at the ends of long bones and in the spine, is more spongy in appearance
(K. Khan et al., 2001). Trabecular bone has a higher rate of bone turnover in
comparison to cortical bone, which makes it more susceptible to bone loss (Hochberg et
al., 2002). More than 50% of the bone in the lumbar spine and in the trochanter of the
femur is trabecular bone, which makes these sites more susceptible to fracture (Meier,
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et al., 2004). Increased tendency to falls is also a reason why postmenopausal women
are at increased risk for hip fractures (Geusens et al., 2002).
The utilization of t-scores and z-scores to express bone mineral density (BMD) is
typical. The t-score is based on comparison of an individual’s bone density to the bone
density of a 25- to 30-year-old of similar gender and race/ethnicity (Winters-Stone,
2005, p. 10). Calculation of an individual’s t-score is performed by using the formula:
(patient’s BMD – young normal mean)/SD of young normal. The individual’s BMD is
compared with the mean value in a population of similar age, sex, and height when
using the z-score (Richmond, 2003). Calculation of an individual’s z-score is performed
by using the formula: (patient's BMD – mean of similar population) / SD of similar
population. Diagnostic criteria for osteoporosis, which is based on an individual’s
BMD t-scores, were established by the WHO (Lane, 2006). The WHO (1994) uses a
threshold of 2.5 standard deviations below the mean of young adult women and a
threshold of 1 to 2.5 standard deviations below the mean of young adult women as the
criterion for a diagnosis of osteoporosis and osteopenia, respectively. These definitions
for osteoporosis and osteopenia, however, are based on BMD measurements in
menopausal White women. Furthermore, applying these criteria to premenopausal
women with low BMD was not the original intention of these definitions (A. Khan, 2006).
Questions have been raised as to whether or not separate race-specific norms should
be used to define osteoporosis and osteopenia in non-White groups (Acheson, 2005). It
is suggested that z-scores, instead of t-scores, be used when examining the BMD of
premenopausal women, children, and men younger than 20 years (Lewiecki et al.,
2004). Furthermore, the use of z-scores is suggested when determining the BMD of
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African Americans on scanners that do not have an African-American reference
database (Richmond, 2003). For the present study, t-scores were utilized for four
reasons: 1) t-scores and z-scores are relatively equal for individuals between the ages
of 19 and 30 years, 2) the densitometer utilized for this study contains an AfricanAmerican database, 3) t-scores rather than z-scores are utilized by the WHO for
diagnostic criteria, 4) and z-scores are not available on the densitometer used in this
study for individuals younger than 18 years.
Bone densitometry, which is used to measure BMD, is one of the most frequently
used techniques in the assessment and management of patients suspected to have
osteoporosis (Ralston, 2005). Several techniques exist that can measure BMD. They
include single-photon absorptiometry, dual-photon absorptiometry, dual-energy x-ray
absorptiometry (DEXA), and quantitative computed tomography (Sievanen, Oja, and
Vuori, 1992). DEXA, however, is considered the gold standard of methods used to
diagnose osteoporosis (Lochmuller, Muller, Kuhn, Lill, and Eckstein, 2003). It delivers a
dose of radiation that is about one tenth of that delivered by a standard chest x-ray
(Vega, de Tejada, Hachero, Cano, and Rodriguez, 1996). Current DEXA technology
uses a fan-beam x-ray source coupled with multi-element solid-state detectors
(Salamone et al., 2000). This results in increased resolution and scan speed.

Risk Factors
Risk factors for osteoporosis can be classified as either primary or secondary.
Primary risk factors for osteoporosis include estrogen deficiency, age, being female,
genetic factors, personal history of fractures in the absence of trauma, thin/small frame,
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diet low in calcium, vitamin D deficiency and reaching menopause either naturally or
surgically before the age of 45 (Amonkar and Mody, 2002). In addition to those listed,
the NOF (2008) also lists diseases and conditions such as anorexia nervosa,
rheumatoid arthritis, and gastrointestinal diseases as well as being of Caucasian, Asian,
or Hispanic/Latino race/ethnicities as risk factors for osteoporosis. Secondary risk
factors include the use of certain drugs such as glucocorticoids and antiepileptics and
lifestyle behaviors such as excessive alcohol consumption, smoking and physical
inactivity (Amonkar and Mody, 2002). Just as risk factors can be considered primary or
secondary, osteoporosis can be classified as either primary osteoporosis or secondary
osteoporosis. Primary osteoporosis is defined as bone loss that occurs during the
normal human aging process while secondary osteoporosis is defined as bone loss that
results from specific, well-defined clinical disorders (Fitzpatrick, 2002).
The U.S. Preventive Services Task Force (as cited by USDHHS, 2004)
recommends routine osteoporosis screening for all women aged 65 and older and
starting at age 60 for women who are at high risk for osteoporosis as a result of having
a body weight less than 70 kg or having a lack of hormone replacement therapy. The
Task Force, however, does not make any BMD testing recommendations for
premenopausal women nor are their screening recommendations race-specific. This
poses a problem since it is possible for premenopausal women and non-White women
to develop low BMD. The Institute for Clinical Systems Improvement, however,
recommends BMD testing for premenopausal women who have had amenorrhea for
more than 1 year (Mauck and Clarke, 2006).
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Approximately 15% of premenopausal women have osteopenia (Kanis, Delmas,
Burckhardt, Cooper, and Torgerson, 1997). Some factors that are linked to low bone
mineral density in premenopausal women include conditions that require the use of
glucocorticoids and anticonvulsants and the eating disorder, anorexia nervosa (Hansen
and Vondracek, 2004). Other factors that are linked to low BMD in premenopausal
women are delayed menarche and amenorrhea (Gourlay and Brown, 2004).

Prevention and Treatment
The NOF (2008) lists 5 steps for bone health and the prevention of osteoporosis:
(1) get recommended amounts of calcium and vitamin D daily, (2) engage in regular
weight-bearing exercises, (3) avoid smoking and excessive alcohol consumption, (4)
discuss bone health with your healthcare provider, and (5) have a bone density test and
take medication when appropriate. Several pharmacological and non-pharmacological
interventions exist for the treatment of osteoporosis. The purpose of the
pharmacological interventions is either to inhibit bone resorption and/or to decrease
bone loss. Bisphosphonates, calcitonins, estrogens and the selective estrogen receptor
modulators and calcium are the 5 major pharmacological categories of drugs used to
treat osteoporosis (Stafford, Drieling, and Hersh, 2004). Bisphosphonates are the drug
of choice with one study showing that they were prescribed 73% of the time during
osteoporosis patients’ visits (Stafford, Drieling, and Hersh, 2004). Non-pharmacological
treatments include weight-bearing exercise, hip protectors, pain management,
rehabilitation to improve mobility, ortheses, back supports and walking aids (Gaudio and
Morabito, 2005; Lips and Ooms, 2000). Improvement of mobility is important because it
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reduces fall-risk. A reduction in fall-risk is important because, a fall from standing height
or less is the cause of approximately 90% of hip fractures in both men and women
(Cummings and Melton, 2002).
Although bisphosphonates are the drug of choice for treating osteoporosis, data
are limited regarding the use of these drugs in premenopausal women who do not have
a secondary cause of bone loss, such as glucocorticoid therapy or an overactive thyroid
gland (A. Khan, 2006). Glucocorticoid therapy causes an increase in bone turnover.
Bisposphonates are beneficial in women who have undergone this type of therapy
because they work by lowering bone turnover (A. Khan, 2006). These drugs, however,
could suppress normal bone turnover rates in women who do not have a secondary
cause of bone loss (A. Khan, 2006). Another reason why bisphosphates are not
typically prescribed to premenopausal women with secondary causes of bone loss is
because they have the ability to be discharged from the bones several years after being
ingested (A. Khan, 2006). This gives them the potential of being released during
pregnancy; and their effects on the bones of fetuses are unknown (A. Khan, 2006).
In order to understand how pharmacological treatments for low bone density
work, the process of bone building and bone resorption must be understood. Bone
contains three types of cells: osteoblasts, osteocytes, and osteoclasts (K. Khan, et al.,
2001). Osteoblasts, which are under the control of endocrine, paracrine, and autocrine
factors, are responsible for producing bone matrix. Osteocytes are mature bone cells
that assist with communication between bone cells and aid in bones response to
mechanical loading. Lastly, osteoclasts are responsible for removing old bone. One
way in which antiresorptive pharmacological agents affect bone cells is by shortening
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the lifespan of osteoclasts and increasing the lifespan of osteocytes and osteoblasts
(Boonen, Haentjens, Vandenput, and Vanderschueren, 2004).

Purpose:
The primary purpose of this research is to explain the variance in BMD in AfricanAmerican and Caucasian college-aged women. A secondary purpose was to evaluate
the differences in osteoporosis knowledge among college-aged African-American and
Caucasian women.

Research question:
What variables account for the variance in BMD among African-American and
Caucasian college-aged women?

Operational Definitions:
Amenorrhea is defined as the absence or suppression of menstruation
(Thomas, 1997).
Anticonvulsant is defined as an agent that prevents or relieves the sudden
onset of involuntary muscular contractions and relaxations (Thomas, 1997).
Anorexia nervosa is defined as an eating disorder marked by excessive fasting
(Thomas, 1997).
Bone matrix is a combination of extracellular proteins arranged to promote
mineral deposition (Marzia et al., 2000).
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Cortical bone is a very dense and calcified type of bone found on the outer parts
of long bones, such as the femur (K. Khan et al., 2001).
Glucocorticoid is defined as a general classification of adrenal cortical
hormones that are primarily active in protecting against stress and in affecting protein
and carbohydrate metabolism (Thomas, 1997).
Menarche (menses) is defined as the initial menstrual period in a woman which
usually occurs between the ages of 9 and 17 years (Thomas, 1997).
Osteoblasts are bone cells responsible for producing bone matrix (K. Khan, et
al., 2001, ch. 1).
Osteoclasts are bone cells that are responsible for the removal of old bone (K.
Khan et al., p. 7, 2001).
Osteocytes are mature bone cells that assist with communication between bone
cells and aid in bones response to mechanical loading (K. Khan, et al., 2001, ch. 1).
Peak bone mass is defined as the maximum amount of bone acquired at the
end of growth (Lafage-Proust, Combe, Barthe, and Aparicio, 1999).
Premature menopause refers to development of amenorrhea due to cessation
of ovarian function before the age of 40 years (Goswami and Conway, 2005).
Premenopausal or premenopause refers to the period in women between the
age of peak bone mass and menopause (Lewiecki, 2004).
Trabecular bone is located at the ends of long bones and in the spine, is spongy
in appearance (K. Khan et al., 2001).
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Null Hypotheses:
HO1:

African-American women’s bone mineral density level will not be
significantly different from Caucasian women’s bone mineral density among low,
normal, and high BMI groups.

HO2:

Women with high BMIs will not have significantly different bone mineral
density than women with low BMIs regardless of ethnicity.

HO3:

Women who have inadequate intake of calcium will not have a significantly
different BMD than women who have an adequate intake of calcium.

HO4:

BMD will not be significantly different in women who currently engage in
regular physical activity in comparison to women who do not engage in
regular physical activity regardless of ethnicity.

HO5:

Women who participated in high school sports will not have significantly different
BMD values than women who have not engaged in physical activity in the past
regardless of ethnicity.

HO6:

Length of time on oral contraceptives will not be significantly related BMD.

HO7:

BMD values will not be significantly different in women who are more
knowledgeable of osteoporosis in comparison to those who are less
knowledgeable.

HO8:

BMD values will not be significantly different between African American and
Caucasian women.

Alternative Hypotheses:
HA1:

African-American women’s bone mineral density level will be significantly
different than Caucasian women’s bone mineral density among low,
normal, and high BMI groups.
12

HA2:

Women with high BMIs will have significantly different bone mineral density than
women with low BMIs regardless of ethnicity.

HA3:

Women who have inadequate calcium intake will have a significantly different
BMD than women who have an adequate intake of calcium.

HA4:

BMD will be significantly different in women who currently engage in regular
physical activity in comparison to women who do not engage in regular physical
activity regardless of ethnicity.

HA5:

Women who participated in high school sports will have
significantly different BMD values than women who have not engaged in
physical activity in the past regardless of ethnicity.

HA6:

Length of time on oral contraceptives will be significantly related to BMD.

HA7:

BMD values will be significantly different in women who are more knowledgeable
of osteoporosis in comparison to those who are less knowledgeable.

HA8:

BMD values will be significantly different between African American and
Caucasian women.

Delimitations:
1. Only African-Americans and Caucasians are included in this study.
2. Only women are included in this study.
3. Participants must be between the ages of 18 and 30, inclusive.

Limitations:
1. All participants will be volunteers. Volunteers are likely to represent a biased
sample because of their interest and motivation to volunteer.
2. The sample of this study will not be a random sample.

13

3. The sample of this study will be selected from Northern Mississippi and therefore
not a nationally representative sample.

Assumptions:
1. Participants can read and understand English.
2. Participants are the race that they report.
3. Participants answer questions honestly.

Significance of Study:
With an increasing aging population and longevity of minority groups,
osteoporosis is increasing as a public health concern (Kidambi, Partington and Binkley,
2005). Some researchers suggest that African American women fracture at a lower rate
when compared to Caucasians with the same bone mineral density but when they do
fracture they have higher mortality and morbidity rates (Barrett-Connor et al., 2005).
Data regarding risk factors and prevalence of low bone mineral density among African
American college women are limited. Caucasian women are at the greatest risk for low
BMD. However, African American women do have osteopenia and osteoporosis. The
primary objective of this research is to explain the variance in BMD in African-American
and Caucasian college-aged women. A secondary objective of this study is to evaluate
knowledge about osteoporosis among college-aged African-American and Caucasian
women.

14

Chapter II
Review of Literature
This chapter contains an extensive review of literature pertinent to the aims of
this study. This chapter is divided into eight sections. The first section discusses peak
bone mass and the importance of attaining this early in life. The second section
explains risk factors of osteoporosis. The third section, which is arguably the most
important section, discusses racial differences in BMD and osteoporosis risk. The
fourth section discusses heredity and how it can play a part in determining osteoporosis
risk. The fifth section discusses nutrient intake and its importance in BMD
determination. The sixth section discusses contraceptive use and its effect on bone
mineral density. The seventh section discusses body composition and body weight and
their possible effect on BMD. The eighth section discusses the importance of type of
physical activity for building or maintaining BMD. Lastly, the ninth section discusses
osteoporosis knowledge.

Peak Bone Mass
Amount of peak bone mass is a major determinant of osteoporosis and fractures
in the elderly (Wren, Kim, Janicka, Sanchez, and Gilsanz, 2007). According to Thomas
(2007), the most important predictor of future fracture risk is peak bone mass. Bone
mineral density acquired by early adulthood can explain 60% of osteoporosis risk
(Bachrach et al., 1999). Peak bone mass is defined as the maximum amount of bone
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acquired at the end of growth (Lafage-Proust et al., 1999). It is generally thought that
women reach peak bone mass in their mid-to-late 20s (Picone, 2004). Other
researchers, however, report BMD peaking at around age 35 years (Cohen and Roe,
2000).
Many factors play a role in the attainment of peak bone mass. These factors
include genetics, nutrition, and exercise in addition to other factors such as tobacco and
alcohol use (Heaney et al., 2000). Ettinger et al. (1997) reports that Black women and
men attain 5-15% more peak bone mass than Whites. Heredity, nutrition, and exercise
will be discussed in a later section.

Risk Factors
Primary risk factors for osteoporosis include estrogen deficiency, age, being
female, genetic factors, thin/small frame, diet low in calcium, vitamin D deficiency, being
of Caucasian, Asian, or Hispanic/Latino race/ethnicities and reaching menopause either
naturally or surgically before the age of 45 (Amonkar and Mody, 2002; NOF, 2008).
The risk of bone loss and osteoporosis increases with age due to increased bone
resorption and decreased bone formation which is a result of the decrease in estrogen
production (Leskela et al., 2003). Women who reach menopause prematurely are at
greater risk for osteoporosis due to their extended time of estrogen deficiency
(Kalantaridou et al., 2006). Estrogen deficiency induces bone loss by causing the
upregulation of osteoclasts (Cencil et al., 2000).
Although most prevention and research protocols with osteoporosis are mainly
designed with the underlying school of thought that African-American and Hispanic
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women have a small chance of developing osteoporosis, these minority groups are
disproportionately affected by some of the main risk factors associated with
osteoporosis (Geller and Derman, 2001). Results from NHANES III show that African
American women tend to have a lower intake of calcium when compared to White and
Hispanic women (Arab, Carriquiry, Steck-Scott, and Gaudet, 2003).
Sex hormones play a role in the differences in BMD among men and women.
Androgens, which are male sex hormones, are thought to increase bone formation
(Orwoll, Belknap, and Klein, 2001). Due to these hormonal differences, women typically
have a smaller/thinner frame than men. Consequently, as a result of their bone
geometry, individuals with small frames are at risk for osteoporosis due to weaker
bones (Lewiecki, 2004). Women are also at greater risk for osteoporosis than men
because they begin with a lower amount of bone mass than men and because they lose
bone mass at a greater rate than men (USDHHS, 2004).
Secondary risk factors include the use of certain drugs such as glucocorticoids
and antiepileptics and lifestyle behaviors such as excessive alcohol consumption,
smoking, anorexia nervosa, rheumatoid arthritis, and gastrointestinal diseases and
physical inactivity (Amonkar and Mody, 2002; NOF, 2008). Glucocorticoids cause
osteoporosis by influencing the production and action of hormones that regulate bone
and calcium metabolism, which in turn causes bone resorption and impaired bone
formation (Mazziotti, Angeli, Bilezikian, Canalis, and Giustina, 2006). Long-term
treatment with antiepileptics can ultimately result in vitamin D deficiency, which
increases risk of osteoporosis (Ma, Kong, Chan, Tong, and Chan, 2007).
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Race
The NOF (2008) states that individuals who are Caucasian, Asian, or
Hispanic/Latino are at increased risk for osteoporosis. When compared to Caucasians,
as well as other ethnicities, African American women tend to have higher BMD values
(USDHHS, 2004 and NIH, 2001). Barrett-Conner et al. (2005) described the prevalence
of low BMD and the relationship between low BMD and 1-year fracture occurrence in
Black, Asian, White, Hispanic, and Native American postmenopausal women 50 years
or older. Results show that Black women had the highest mean t-score, whereas, Asian
women had the lowest mean t-score. It was also found that White and Hispanic women
had the greatest risk for fractures and that Asian women had the lowest risk for
fractures, although Asian American women have lower BMD values (Barrett-Conner et
al, 2005). Finkelstein et al. (2002) also found that African-American women between
the ages of 42 to 52 years old had higher BMD values in the femoral neck and lumbar
spine when compared to Caucasian, Chinese, and Japanese women.
Differences in BMD between races in young adults have been tested as well.
Ettinger et al. (1997) tested whether or not differences in bone density between Black
and White males and females between the ages of 25-36 years can be explained by
differences in bone metabolism and lifestyle. Their results show that both male and
female Blacks had significantly higher BMDs at all skeletal sites in comparison to White
males and White females.
Though studies continuously show that African Americans have higher BMD than
other ethnic groups, this does not mean that African Americans are without risk
regarding osteoporosis. Currently, over 300,000 African-American women have
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osteoporosis (Kessenich, 2000). Results from the National Osteoporosis Risk
Assessment (NORA), a longitudinal observational study examining the incidence, risk
factors, and fracture incidence of low BMD in postmenopausal women showed that 32%
of African-American women had osteopenia and 4% had osteoporosis (Siris et al.,
2001). Moreover, Kidambi, Partington and Binkley (2005) found that when examining
the quantitative calcaneal ultrasound results of 150 Wisconsin, African-American
women aged 45 years and older, 33% had low bone mass. Additionally, only 25% of
the study sample surveyed believed that they were at moderate to high risk for
osteoporosis.

Heredity
The NOF (2008) lists family history as a risk factor for osteoporosis. It is believed
that a variety of genes that control bone building and bone loss are involved in the
development of osteoporosis (Rizzoli, Bonjour, and Ferrari, 2001). The determinants of
bone strength, including BMD, peak bone mass, bone geometry, and bone metabolism,
are influenced by genetics (Bohannon, 1999). Up to 80% of the differences seen in
peak BMD can be attributed to genetic factors (Koller et al., 2000). Hip fractures are
twice as likely to occur in women with a maternal history of hip fracture in comparison to
women without a maternal history of hip fracture (Lane, 2006).

Nutrient Intake
The bones and teeth house over 99% of total body calcium in humans
(Cashman, 2002). According to the NOF (2008), a diet low in calcium is a risk factor for
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osteoporosis. Although heredity can contribute up to 80% of the differences seen in
peak BMD, up to 40% of the variability seen in peak bone mass can be attributed to
environmental factors, including diet (Koller et al., 2000; Lewiecki, 2005). Some of the
vitamins that are shown to have an effect, whether substantial or negligible, include
calcium, vitamin D, iron, zinc, and magnesium. A deficiency in magnesium can affect
bone density indirectly. Calcium metabolism is altered when there is a deficiency in
magnesium (Ilich and Kerstetter, 2000). Dairy product intake is a measure of calcium
intake due to the abundance of calcium in dairy products; especially milk (Heaney,
2000). Food frequency questionnaires are commonly used to measure dietary intake in
research studies due to the low cost associated with their use (Sebring et al., 2007).
Although the recommended dietary reference intake (DRI) for calcium is 1300 mg
for individuals ages 9 to 18 and 1000 mg for individuals ages 19 to 50, only 19% of
females ages 9 to 18 and 40% of women ages 19 to 50 are currently meeting these
requirements (Beaudoin and Blum, 2005). The percentages of females not meeting the
DRI are even higher when examining minority populations. Lactose maldigestion’s high
prevalence among minority groups, especially non-Hispanic African Americans, is
typically cited as the culprit for low intake among minority populations (Jackson and
Savaiano, 2001). Lactose maldigestion occurs in 70% to 75% of Blacks (Buchowski,
Semenya, and Johnson, 2002). Some evidence exists that there is an increased
prevalence of osteoporosis among lactose maldigestors due to their avoidance of dairy
products (Jackson and Savaiano, 2001).
The effect that calcium has on bone density and fracture risk has been debated.
One study found that higher intakes of vitamin D and calcium reduced osteoporosis risk
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but not 3-year fracture risk in Caucasian women (Nieves et al., 2008). Another study
conducted in Sweden showed that calcium and vitamin D intake in women estimated at
middle age and older age is not of major importance in the primary prevention of
osteoporotic fractures (Michaelsson, Melhus, Belloco, and Wolk, 2003). Wallace and
Ballard (2002) found that lifetime calcium consumption was not a significant predictor of
BMD or bone mineral content (BMC) in premenopausal Caucasian women, although
current calcium consumption contributed to the total variance in BMD. Prince et al.
(2006), however, found that supplementation with 1200 mg of calcium carbonate tablets
in elderly women reduced the risk of clinical fracture in those who adhered to the
protocol. According to Heaney (2001), osteoporotic fracture risk can be reduced by
30% to 50% by increasing calcium intake in the over-65 population. Ramsdale et al. (as
cited in Gourlay and Brown, 2004) found a significant correlation between calcium
intake and BMD at the neck of the femur (r = .41), the Ward’s triangle of the femur (r =
.40) and the trochanter of the femur (r = .47) and at the spine (r = .27) in healthy
premenopausal women aged 21 to 47 years. Harris et al. (2003) also found that
calcium, magnesium, phosphorus, zinc and vitamin D had positive significant
associations with BMD.

Contraceptives
Some evidence exists that the use of oral contraceptives by women decreases
the risk of osteoporosis. A study of 710 Australian women ages 20 to 69 showed that
premenopausal women who had been exposed to oral contraceptives had lumbar spine
bone density values that were 3.3% higher than those not exposed to oral
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contraceptives (Pasco et al., 2000). All studies have not shown an increase in bone
density as a result of oral contraceptive use. Prior et al. (2001) looked at oral
contraceptive use and BMD changes in 524 women ages 25 – 45 years. They
observed lower BMD values in premenopausal women who used oral contraceptives
when compared to premenopausal women who had never used them. Another study
examining oral contraceptive use and BMD changes over a 36-month period in women
aged 18 to 39 years concluded that oral contraceptive did not appear to have any
impact on bone density during the study period (Reed et al., 2003).
One contraceptive of concern is depot medroxyprogesterone acetate (DMPA),
also known as Depo-Provera, which is injected intramuscularly. This particular
contraceptive is of concern due to its ultimate suppression of estrogen production from
the ovaries (Albertazzi, Bottazzi, and Steel, 2006). Walsh, Eastell, and Peel (2008)
found that that DMPA use was associated with a 5% bone density deficit at the hip and
spine in Caucasian women who starting using it before the age of 20. This deficit,
however, was not seen in women who began using Depo-Provera after the age of 34.
Another study comparing BMD changes in first-time DMPA users to BMD changes in
nonusers found that BMD of the hip and spine declined after each injection during the
entire 24 month study period in comparison to a less than 1% decline in nonusers
(Clark, Sowers, Nichols, and Levy, 2004). Since the adverse effects of DMPA on bone
are most pronounced in those who have not attained peak bone mass, it is
recommended that DMPA not be used in women prior to this attainment (Lewiecki,
2005).

22

Body Composition/Weight
The link between body composition and BMD is well established, especially in
older adults. Coin et al. (2000) determined the relationship between nutritional status
and bone mass with body composition. Subjects included 60 women, 30 of whom were
underweight and 51 men, 30 of whom were underweight. The low weight women had a
mean age of 81.3 years and the low weight men had a mean age of 80.8 years. When
looking at bone mineral content (BMC) and bone mineral density (BMD) at the femoral
level, both genders of underweight patients had lower values when compared to normal
subjects. Bone turnover were within normal range for the underweight and normal
weight individuals. In both men and women for the entire subject population, whole
body BMD correlated with fat-free soft mass (r = .34 and r = .31, respectively). BMD
correlated with appendicular skeletal muscle mass (r = .35) in men only. It was
concluded that, in addition to other factors, malnutrition and osteoporosis is associated
with low weight in the elderly.
Glauber et al. (1995) examined the relationship between bone density and
weight, body mass index, height, adiposity, regional fat distribution, and frame.
Subjects were 6,705 non-Black women with an average age of 71.2 years. Data on
lifestyle and health-related behaviors were collected as well as weight, height, waist-tohip ratio, knee height, and elbow width. Single- photon absorptiometry was used to
measure BMD at the distal and proximal radius and the calcaneous during the first visit.
Dual-energy x-ray absorptiometry was used to measure BMD of the lumbar spine and
femoral neck. Bioelectrical impedance analysis was used to measure adiposity. Weight
accounted for over 81% of the variability of adiposity on BMD at weight-bearing sites.

23

Thirty-two to 47 % of the effects of adiposity on BMD could be accounted for by weight
at non-weight bearing sites. Proximal femoral BMD increased with increases in body
weight. Weight, however, did not influence the relationship between BMD and age. It
was concluded that due to its loading effects on the skeleton, weight as the major
anthropomorphic determinant of bone density in late postmenopausal women.
Ettinger et al. (1997) tested whether or not differences in bone density between
Black and White males and females could be explained by differences in bone
metabolism and lifestyle. Subjects included 109 and 95 Black men and women,
respectively, and 114 and 84 White men and women recruited from the Kaiser
Permanente Medical Care Program as a part of the CARDIA study. DEXA of total body,
hip, lumbar spine, lean body mass, fat mass, and ratio of trunk to leg fat was performed
using a densitometer. Muscle strength of the quadriceps and hamstrings were
assessed with a dynamometer. Bone markers and mineral metabolism markers
creatinine, calcium, phosphorus, bone-specific alkaline phosphatase, intact parathyroid
hormone, 25D, 1,25 D, and osteocalcin were attained through blood draws. Growth
factors and level of sex and adrenal hormones were also measured. Physical activity,
diet habits, and medical history including history of tobacco and alcohol use were
assessed. Results show that physical activity was higher in Black men than White men
but was higher in White women in comparison to Black women. Higher intakes of
calcium and vitamin D were seen in White women in comparison to Black women.
Smoking and weight were higher in black subjects in comparison to white subjects.
Black men had lower abdominal fat than White men whereas Black women had higher
abdominal fat than White women. Blacks had significantly higher BMDs at all skeletal
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sites in comparison to white subjects. Calcium and vitamin intake were higher in White
women than in Black women. No significant differences were seen among men. Black
men and women had lower levels of 25D and higher 1,25D levels in comparison to their
White counterparts. This study concluded that clinical and biochemical variables
measured in young adulthood does not explain racial differences in BMD.
Other studies have focused on children and young adults to establish the
relationship between BMD and body composition. Rollins, Imrhan, Czajka-Narins, and
Nichols (2003) assessed lumbar spine and femoral neck BMD values in 61 Caucasian
women aged 18 to 30 years. These women were all healthy and did not have any
known risk factors that would place them at apparent risk for secondary osteoporosis.
Participants were divided into a lower weight group (BMI of 16.0 to 19.9) and a normal
weight group (BMI 23.0 to 25.9). Results showed that 9 of the 30 women in the lower
weight group had spinal BMD values in the osteopenic range, according to the WHO
criteria, in comparison to 2 of the 31 women in the normal weight group who had
osteopenic spinal BMD values. Furthermore, none of the normal weight participants
had femoral neck BMD values within the osteopenia range in comparison to 3
participants having femoral BMD values within the osteopenia rage.
Young et al. (2001) sought to determine the degree of association between
longitudinal changes in bone mineral density and body composition in female twins.
The subjects included 104 paired female twins and 78 unpaired female twins with their
subjects being aged 8 to 25 years. Their subjects were registered with the Australian
Twin Registry. Dual energy x-ray absorptiometry (DEXA) was used to measure total
body fat, total body lean mass, and total body bone mineral content (BMC) as well as
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bone mineral density (BMD) at the lumbar spine, femoral neck and total hip. Data on
menarchial status and height measurements were also taken. Results showed that
height increased and changes in lean mass were the greatest 1-year before menarche.
Changes in fat mass, BMD at the hip and lumbar spine, and total BMC were at their
largest around the age of menarche. Association results were reported in annual
percent changes in lumbar spine and hip areal BMD and total BMC against annual
changes in lean and fat mass and height rather than with correlation values. Changes
in lean mass, fat mass and height were associated with changes in BMD at the lumbar
spine, femoral neck, total hip, and total body BMC during the linear growth phase. For
the post-linear growth phase, femoral BMD changes and total body BMC were
associated with changes in lean mass and fat mass. It was concluded that lean mass
plays a role in building bone during linear growth and that fat mass plays some part in
maintaining bone density during post-linear growth.
Reid, Plank, and Evans (1992) evaluated the relationship between bone mineral
density (BMD) and body composition in men and premenopausal women. Subjects
included 68 healthy premenopausal women and 51 healthy men all of which were
White. Dual-energy x-ray absorptiometry was used to measure total BMD. Height and
weight measurements were also taken for each of the subjects. Multiple regression
analysis and correlation coefficients were used to analyze the data. Results show that
men were taller and had higher BMDs and lean mass in comparison to women. Fat
mass increased with age in women but not in men. Weight, and lean mass were closely
associated with BMD in both men and women (r = .56 compared to .69, and .51
compared to .55 respectively), whereas BMD was related to fat mass in women only (r =
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.60). When BMD was expressed as a ratio to height, it was closely associated with fat
mass in women (r = .57) and just attained significance in men (r = .28). When multiple
regression was used to look closer at the relationship between fat and lean mass and
BMD, lean and fat mass were associated with BMD in women only (R2 = .48). The
researchers concluded that although fat mass is related to bone mineral density in
women, it is not related to bone mineral density in men.
Wang et al. (2005) attempted to validate the reported findings that amount of
lean tissue and fat mass affects bone mass and to differentiate between the affect of
each of these masses on bone mass. Subjects included 317 African American women,
154 Asians, 322 Caucasians, and 128 Latinas who were ages 20-25 years and who had
no known diseases that would affect bone mass. Height, weight, and reproductive
history were recorded. Dual-energy X-ray absorptiometry was used to measure lean
tissue mass, fat mass, and bone density of the spine, left proximal femur, and whole
body. Multiple linear regression, ANOVA, and Bonferroni’s techniques were used to
analyze the data. Results show that African Americans had the highest mean weight,
fat mass and lean tissue whereas Asians had the lowest of all of these. African
Americans had the highest bone density and Asians had the lowest at most sites. Fat
mass had a significant positive correlation with femoral neck BMD (r = .23). Lean mass
and weight had significant positive correlations ranging from 0.34 to 0.76 with femoral
neck BMD, whole body BMD, whole body BMC, and whole body BMC/height. Except
for bone mineral apparent density, lean mass had a significantly greater effect on bone
density than fat mass for all bone density measures in multiple linear regression. It is
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concluded that lean tissue mass has a greater effect on bone density than does fat
mass in young women.

Physical Activity
Osteoporosis is one of the many chronic diseases that can result from a lack of
physical activity. Therefore, engaging in physical activity can help prevent osteoporosis.
Wolff’s Law can explain the mechanism by which exercise improves bone density.
Wolff’s Law describes bones’ ability to adapt to physical strains that are placed on them
(K. Khan et al., 2001, ch.3, p. 27). Since some of the available pharmacological
therapies are not typically recommended in premenopausal women with low BMD,
prevention of osteoporosis through diet and exercise is preferable (Lewiecki, 2005). It is
important to start these prevention methods early. Studies have shown that Caucasian
female adults who participated in sports during their teenage years had a significant
increase in femoral BMD compared to those who were sedentary as a teenager (Ford,
Bass, Turner, Mauromustakos, and Graves, 2004; Lloyd et al., 2000).
When examining Wolff’s Law, it is noted that the more strain that is put on the
bones, the stronger they become. This is the reason why strength training is so
effective in building BMD. In a meta-analysis of controlled trials looking at the effect of
resistance training on BMD in women, it was concluded that resistance training has a
positive effect on spinal BMD in pre- and postmenopausal women (Kelley, Kelley, and
Tran, 2001). This same meta-analysis also found that resistance training had a positive
effect on BMD in the femur and radius of postmenopausal women (Kelley, Kelley, and
Tran, 2001).
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Although the benefits of physical activity have been well researched, some ethnic
groups are not taking advantage of these benefits. When observing physical activity in
American society, minority women are among the least active subgroups (Geller and
Derman, 2001). Furthermore, physical activity is lower in African-American women than
all other ethnic groups except for Mexican-American women (Adams-Campbell et al.,
2000). This lack of physical activity among this group places them at increased risk for
osteoporosis.

Osteoporosis Knowledge
It is possible that osteoporosis prevalence is linked to a lack of knowledge
regarding the disease and its risk factors (Wilson, 2007). Although one would think that
knowledge of what is healthy and what is unhealthy will cause a behavior change,
knowledge alone is often not enough to cause a behavior change (Wallace, 2002).
Studies have shown that women are typically aware that lack of physical activity and
low calcium intake are risk factors for osteoporosis (Kasper, Peterson, and Allegrante,
2001; Ford, Bass, and Keathley, 2007). However, women are more likely to be
unaware that factors such as amenorrhea and menopause put them at increased risk
for osteoporosis (Kasper, Peterson, and Allegrante, 2001). For this study, osteoporosis
knowledge will be assessed using the Osteoporosis Knowledge Test (OKT) developed
by Kim, Horan, Gendler, and Patel (1991).
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Chapter III
Methodology
The primary purpose of this research is to explain the variance in BMD in AfricanAmerican and Caucasian college-aged women. A secondary purpose was to evaluate
the differences in osteoporosis knowledge among college-aged African-American and
Caucasian women. This chapter includes a discussion of the subjects, a description of
the surveys used, step-by-step data collection procedures, measurements of variables,
and treatment of the data. This chapter is divided into the following sections: (1)
subjects, (2) subject selection, (3) laboratory procedures, (4) equipment, and (5)
statistical analysis.

Subjects
Participants were 18-30 year-old African American and Caucasian females
identified in three groups: (a) low weight, (b) normal weight, and (c) high weight. Power
analysis indicated that a total of 72 subjects were needed to attain a power of .80 with
an estimated effect size of .30 at an α-level of .05.

Subject Selection
Participants were recruited by email, advertising in University classrooms and on
bulletin boards around the University as well as in doctors’ offices, in local churches,
and in local newspapers. Participants were included if they were between the ages of
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18 and 30, and did not have any conditions that would place them at apparent
risk (celiac disease, corticosteroid use, and amenorrhea) for low bone mineral density.
As documented in the initial phone screening, potential participants were questioned
about apparent osteoporosis risk factors. The purpose of this questioning was to
determine if any risk factors would be potential contributors to the current study. Upon
initial phone contact with the principal investigator (PI), participants were screened over
the phone as described in detail on the form “Initial phone contact with potential
participant” (Appendix A). The initial phone screening process determined preliminary
eligibility based on the inclusion/exclusion criteria described. Secondary eligibility was
based on the results of the pre-DEXA pregnancy test required prior to an initiation of
DEXA scan. Once a participant was deemed preliminarily eligible, the participant was
scheduled to come in for the initial visit.
The respective procedures presented no more than minimal risk of harm to the
involved participants and involved no procedures for which written consent is normally
required outside of the research context. In addition, written informed consent was
obtained at the initial visit prior to any research activities. This study was approved by
the University of Mississippi’s Institutional Review Board (IRB Protocol 07-076).

Laboratory Procedures
All participants were required to meet with the researcher on two occasions. The
following procedures were followed with all participants during their initial visit:
1. Each participant met researcher in the lobby of the Turner Center and then was
escorted to the Body Composition and Bone Mineral Density Laboratory.
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2. Each participant was asked to read and sign the informed consent form provided.
3. Each participant was asked to complete a demographic questionnaire approximately 10 minutes (Appendix D).
4. Each participant was instructed on how to and asked to complete the 7-day
Physical Activity Recall instrument – approximately 10 minutes (Appendix C).
5. Each participant was instructed on how to complete a four-day food log that
includes 2 weekdays and 2 weekend days – approximately 10 to 15 minutes
(Appendix E).
6. Each participant was asked to complete the Osteoporosis Knowledge Test –
approximately 10 minutes (Appendix B).
7. The researcher gave a sterile urine specimen container to each participant and
then gave directions.
8. The researcher escorted the participant to the restroom and obtained the sample
from the participant once completed.
9. The researcher and the participant returned to the Body Composition and Bone
Mineral Density Laboratory where the researcher analyzed the sample
(approximately 5 minutes total). If the pregnancy test was positive, the
researcher did not perform a DEXA scan on the participant because of this
positive reading. This is due to the risks associated with radiation exposure to an
unborn fetus. In turn, the participant was ineligible to participate in the study
based on the documented exclusion criteria. No potential participant in this study
had a positive pregnancy test reading.
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10. After the negative pregnancy test result, each participant was asked to remove
all metal objects in preparation for the DEXA scan.
11. Height and weight was obtained using a Detecto scale (Webb City, MO) with the
participant’s shoes removed (approximately 2 minutes).
12. Each participant was asked to lie on the DEXA table where non-dominant
femoral BMD, anterior posterior (AP) spinal BMD, and total body composition
assessment was performed by a trained DEXA technician using the procedure
outlined in the Hologic user’s manual (approximately 15 minutes total).

Leg

dominance is established by coordinative preferences (i.e. kicking a ball) (Sone,
Imai, Joo, Onodera, and Fukunaga, 2006) in current literature. The researcher
asked each participant the following question: If you were to kick a ball, which
leg/foot would you likely kick with?
13. Each participant scheduled a day and time, which could not occur sooner than 5
days after the first meeting, to submit food records, to confirm foods that were
written in their food record, and to obtain DEXA scan results.
The following procedures were followed with all participants during their second
visit:
1. Each participant met the researcher in the lobby of the Turner Center and then
was escorted to the Body Composition and Bone Mineral Density Laboratory.
2. Each participant was asked to confirm foods that were written in their food
records (15-20 minutes).
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3. Each participant had the results of their DEXA scans explained and was given a
copy of the results (5 minutes).
4. Each participant was given the opportunity to ask questions.

Equipment
DEXA Machine
The Body Composition and Bone Mineral Density Laboratory at the University of
Mississippi houses a Hologic Delphi-W (Hologic, Waltham, MA) DEXA machine. This
machine is used to measure BMD and body composition. t-scores and z-scores are
used to express BMD. The t-score is based on comparison of an individual’s bone
density to the bone density of a 25- to 30-year-old, typically the age of peak bone mass,
of similar gender and race/ethnicity (Winters-Stone, 2005, p. 10). The individual’s BMD
is compared with the mean value in a population of similar age, sex, and height when
using the z-score (Richmond, 2003).
Surveys
Osteoporosis knowledge was assessed using the Osteoporosis Knowledge Test
(OKT) developed by Kim, Horan, Gendler, and Patel (1991). The 24-item, selfadministered, multiple-choice questionnaire has two subscales: OKT calcium and OKT
exercise whose reliability coefficients for internal consistency are 0.72 and 0.69
respectively.
Physical activity was assessed using a 7-day Physical Activity Recall (Dishman
and Steinhardt, 1988). Physical activity ranged from 0 to 7. Participants will receive 1
point for each day of the week that they exercised a total of at least 30 minutes. If the
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total is ≥ 5, then the participant will be considered to have met the physical activity
requirement.
All researchers underwent a one-day training session to learn how to instruct
participants on how to record their food intake. During their initial visit, each participant
was given instructions on how to record their food intake over the next 4 days.
Licensed technicians entered food records into the 4.01 software version of the Nutrition
Data System for Research (NDS-R). The NDS-R, which calculates nutrient intake, is a
dietary analysis program that was developed by the Nutrition Coordinating Center at the
University of Minnesota in 1998.
Anthropometric Data
The height and weight of all participants were taken using a balance scale
(Detecto, Webb City, MO) located in the Body Composition and Bone Mineral Density
Laboratory. BMI, which is calculated using participant’s weight in kilograms divided by
height in meters squared, ranged from 16.6 to 36.6.

Statistical Analysis
This study included women between the ages of 18 and 30. Power analysis for
multiple linear regression (Cohen and Cohen, 1983) indicated that a total of 72 subjects
were needed to attain a power of .80 with an effect size of .30 at an α-level of .05. The
rule of thumb, however, is 10 subjects per independent variable (Darlington, 1990). The
following independent variables were included in the analysis to explain the variance in
spinal BMD and femoral BMD: age, physical activity, calcium intake, oral contraceptive
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use, family history of osteoporosis, BMI, and race. Based on the rule of thumb and if all
7 predictor variables are used, a total of 70 subjects are recommended.
Data were examined for missing data and outliers.

Values for the variance

inflation factor were examined for each independent variable to determine whether or
not collinearity existed. The univariate associations between the dependent variables
(lumbar spine BMD and femoral BMD) and the previously mentioned independent
variables were examined.

For spine and femoral skeletal sites, BMD values were

compared among the two ethnic groups (African-American and Caucasian) by using
ANOVA. To determine whether observed ethnic differences in BMD are due to ethnic
variation in factors that affect BMD were compared again with lumbar spine BMD and
femur BMD values using multivariate linear regression.
SPSS version 17.0.
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Data were analyzed using

Chapter IV
Results
The primary purpose of this research project was to explain the variance in BMD
in African-American and Caucasian college-aged women. A secondary purpose was to
evaluate the differences in osteoporosis knowledge among college-aged AfricanAmerican and Caucasian women. This chapter is presented in the following sections:
(1) description of the sample, (2) survey responses, (3) nutrition, (4) Osteoporosis
Knowledge Test responses, (5) univariate results, (6) multivariable results, and (7)
summary of results and formal hypotheses.

Description of the Sample
A total of 107 women ages 18 – 30 years old, which live in a southern state, were
enrolled in this study. Six participants were not used in the statistical analyses due to:
dual hip surgeries (n = 2), multiple episodes of amenorrhea (n = 1), bone marrow
transplant (n = 1), and non-completion of the study due to time constraints (n = 2).
Therefore, 101 participants were included in the analyses. African-American women
comprised 49.5% of the sample. Caucasian women comprised 50.5% of the sample.
Table 4-1 summarizes the demographics of the study population. African-American and
Caucasian women had similar demographics in terms of their mean age,
anthropometric measures, and BMD scores. The mean age of African-American
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women was 21.00 years (±1.75), whereas the mean age of Caucasian women was
approximately 21.55 years (±2.62). There were, however, significant differences
between African-American and Caucasian participants regarding total hours of exercise
and calcium intake.
Table 4 – 1
Mean and Standard Deviation (SD) of Demographics/Characteristics Overall and by Race

Demographics

African
American
(n = 50)

SD

Caucasian
(n = 51)

SD

Overall
(N = 101)

SD

Age (Years)

21.00

±1.75

21.55

±2.62

21.30

±2.24

Body Mass Index

23.80

±4.87

22.96

±3.81

23.40

±4.37

Spinal BMD (t-score)

-0.57

±1.04

-0.40

±1.01

-0.49

±1.02

Femoral BMD (t-score)

0.30

±0.89

0.52

±1.05

0.41

±0.98

Hours of Exercise

3.36

±4.39

7.69

±7.53

5.54

±6.52*

Grams of Calcium

0.75

±0.29

0.98

±0.44

0.87

±0.39*

19.04

±25.02

29.75

±30.35

24.50

±28.22

Length of Time on Oral
Contraceptives (months)
*p < 0.05

For the purposes of this study, participants were stratified into three weight
categories: 1) low weight if BMI ≤ 20.4 kg/m2, 2) normal weight if 20.5 ≤ BMI kg/m2 ≤
24.4 kg/m2 and 3) high weight if BMI ≥ 24.5 kg/m2. Participants were stratified in this
way closely emulate the BMI cutoffs set by the World Health Organization [WHO]. The
WHO’s cutoffs are as follows: 1) underweight if BMI < 18.5 kg/m2, 2) normal weight if
18.5 kg/m2 < BMI ≤ 24.9 kg/m2, and 3) overweight if BMI ≥ 25 kg/m2 (World Health
Organization, 2000). The number of participants by race for each of the weight
categories is provided in Table 4-2. Among African Americans, 42% were of a highweight status (BMI ≥ 24.5 kg/m2) whereas 26% were of low-weight status (BMI ≤ 20.4
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kg/m2). There was a 1:1 ratio of Caucasian women of a low-weight status (BMI ≤ 20.4
kg/m2) compared to Caucasian women of a high-weight status (BMI ≥ 24.5 kg/m2).
Table 4 – 2
Mean, Minimum and Maximum Values for Body Mass Index (BMI) Categories with SD* Overall and by
Race
Weight Categories
2
Low: BMI ≤ 20.4 kg/m
African-American
Caucasian
2

Normal: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
African-American
Caucasian
High: BMI ≥ 24.5 kg/m
African-American
Caucasian
*Standard Deviation

2

2

N
31
13
18

Min.
94.0
94.0
105.0

Max.
149.5
125.0
149.5

Mean
113.8
109.4
116.9

SD
10.9
10.5
10.3

31
16
15

109.0
109.0
118.0

155.0
150.0
155.0

133.7
130.5
137.2

11.8
11.9
11.1

39
21
18

133.0
144.0
133.0

222.0
222.0
201.0

164.7
169.0
159.6

20.2
22.0
17.2

The mean spinal BMD for each race and weight category is provided in Table 4 –
3. The mean spinal BMD was higher in individuals belonging to the high-weight
category (BMI ≥ 24.5 kg/m2) in comparison to the low-weight category (BMI ≤ 20.4
kg/m2). It is noteworthy that Caucasians in the low-weight group (BMI ≤ 20.4 kg/m2) had
a higher maximal spinal BMD than African Americans in that same weight category.
Significance testing of these findings will be discussed in detail later in this chapter.
The mean femoral BMD for each race and weight category is provided in Table 4
– 4. Similar to the mean spinal BMD, the mean femoral BMD was higher in individuals
belonging to the high-weight category (BMI ≥ 24.5 kg/m2) in comparison to the lowweight category (BMI ≤ 20.4 kg/m2). Also, similar to that seen with mean spinal BMD,
Caucasians in the low-weight group and in the normal weight group (20.5 ≤ BMI kg/m2 ≤
24.4 kg/m2) had higher maximal femoral BMDs than African Americans in each
comparison weight category (2.30 versus 0.90, and 2.40 versus 2.30, respectively).
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Table 4 – 3
Mean, Minimum and Maximum Spinal BMD Values with SD* for Race and Weight Categories
Weight Categories
2
Low: BMI ≤ 20.4 kg/m
African-American
Caucasian
2

Normal: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m

2

African-American
Caucasian
High: BMI ≥ 24.5 kg/m

2

African-American
Caucasian
*Standard Deviation

N
31
13
18

Min.
-2.70
-2.60
-2.70

Max.
1.60
0.70
1.60

Mean
-0.82
-0.98
-0.71

SD
0.98
0.98
1.00

31
16
15

-2.10
-2.10
-2.10

1.20
1.20
0.90

-0.72
-0.90
0.61

0.93
0.92
0.86

39
21
18

-1.80
-1.70
-1.80

2.40
2.40
1.80

-0.03
-0.07
0.88

0.97
0.98
1.10

Table 4 – 4
Mean, Minimum and Maximum Femoral BMD Values with SD* by Race and Weight Categories
Weight Categories
2
Low: BMI ≤ 20.4 kg/m
African-American
Caucasian
2

Normal: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
African-American
Caucasian
High: BMI ≥ 24.5 kg/m
African-American
Caucasian
*Standard Deviation

2

2

N
31
13
18

Min.
-1.70
-1.50
-1.70

Max.
2.30
0.90
2.30

Mean
0.00
-0.12
0.08

SD
0.94
0.80
1.04

31
16
15

-1.20
-1.20
-0.70

2.40
2.30
2.40

0.47
0.34
0.61

0.86
0.86
0.86

39
21
18

-1.00
-0.90
-1.00

2.50
2.50
2.10

0.67
0.52
0.88

1.01
0.92
1.10

Spinal BMD categories for each weight category for entire sample are
summarized in Table 4 - 5. Individuals were classified as having low spinal BMD if their
t-score was ≤ -1.0. They were classified as having normal spinal BMD if their t-score
was > -1.0. Among the 31 participants who were of a low-weight status (BMI ≤ 20.4
kg/m2), nearly 55% also had low spinal BMD. It is also worth mentioning that 17.9% of
those of a high-weight status (BMI ≥ 24.5 kg/m2) also had low spinal BMD.
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Table 4 – 5
Body Mass Index Categories by Spinal Bone Mineral Density Categories of All Participants (%)
Spinal BMD Categories
Low BMD
Normal BMD
n (%)
n (%)

Weight Categories
Low weight: BMI ≤ 20.4 kg/m

2

2

Normal weight: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
High weight: BMI ≥ 24.5 kg/m

2

2

Total

Total

17 (43.6%)

14 (22.6%)

31

15 (38.5%)

16 (25.8%)

31

7(17.9%)

32 (51.6%)

39

39

62

101

Femoral BMD and weight categories for the entire sample are summarized in
Table 4 - 6. Individuals were classified as having low femoral BMD if their t-score was ≤
-1.0 and as having normal femoral BMD if their t-score was > -1.0. The study sample
had a higher prevalence of low spinal BMD than low femoral BMD (38.6% versus 7.9%,
respectively). Individuals who were of a low weight status (BMI ≤ 20.4 kg/m2), were
more than four times as likely to have low femoral BMD in comparison to those who
were of a normal or high weight status (20.5 ≤ BMI kg/m2 ≤ 24.4 kg/m2 and BMI ≥ 24.5
kg/m2). Refer to Figure 1 and Figure 2 in Appendix F for a graphical representation of
how participants with low spinal and femoral BMD compare with participants with
normal spinal and femoral BMD according to demographics/characteristics.
Caucasians’ spinal BMD status and weight category are summarized in Table 4 –
7. It is noteworthy that 35.3% of Caucasian participants had low spinal BMD (t-score < 1.0). Half of the Caucasians with low spinal BMD were classified as having a low
weight (BMI ≤ 20.4 kg/m2) whereas 22.2% were classified as having a high weight (BMI
≥ 24.5 kg/m2). The remaining 27.8% of those with low spinal BMD were classified as
having a normal weight (20.5 ≤ BMI kg/m2 ≤ 24.4 kg/m2).
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Table 4 – 6
Body Mass Index Categories by Femoral Bone Mineral Density Categories of All Participants (%)
Femoral BMD Categories
Low BMD
Normal BMD
n (%)
n (%)

Weight Categories
Low weight: BMI ≤ 20.4 kg/m

2

2

Normal weight: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
High weight: BMI ≥ 24.5 kg/m

2

2

Total

Total
N

6 (75.0%)

25 (26.9%)

31

1 (12.5%)

30 (32.3%)

31

1 (12.5%)

38 (40.9%)

39

8

93

101

Table 4 – 7
Body Mass Index Categories by Spinal Bone Mineral Density Categories of Caucasians (%)
Spinal BMD Categories

Low BMD
n (%)

Weight Categories

Low weight: BMI ≤ 20.4 kg/m

2

2

Normal weight: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
High weight: BMI ≥ 24.5 kg/m

2

2

Total (N)

Normal BMD
n (%)

Total

9 (50.0%)

9 (27.3 %)

18

5 (27.8%)

10 (30.3%)

15

4 (22.2%)

14 (42.4%)

18

18

33

51

Caucasians’ femoral BMD status and weight category are summarized in Table 4
– 8. Among the Caucasian participants, 7.8% had low femoral BMD values (t-score < 1.0) with 75% of those with low femoral BMD being found in the low weight group (BMI
≤ 20.4 kg/m2). The remaining 25% were in the high weight group (BMI ≥ 24.5 kg/m2).
African Americans’ spinal BMD status and weight category are summarized in
Table 4 – 9. It is noteworthy that 42% of African-American participants had low spinal
BMD (t-score < -1.0). Among those with low spinal BMD, 38% were classified as low
weight (BMI ≤ 20.4 kg/m2) whereas 14.3% of a high weight (BMI ≥ 24.5 kg/m2). The
remaining 47% with low spinal BMD were classified as having a normal weight (20.5 ≤
BMI kg/m2 ≤ 24.4 kg/m2). The presence of low spinal BMD (t-score < -1.0) was more
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prevalent in African-American participants, who had 21 individuals with low spinal BMD,
in comparison to Caucasian participants, who had 18 individuals with low spinal BMD
(42% versus 35.3%, respectively).
Table 4 – 8
Body Mass Index Categories by Femoral Bone Mineral Density Categories of Caucasians (%)
Femoral BMD Categories
Low BMD
Normal BMD
n (%)
n (%)

Weight Categories
Low weight: BMI ≤ 20.4 kg/m

2

2

Normal weight: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
High weight: BMI ≥ 24.5 kg/m

2

2

Total (N)

Total

3 (75.0%)

15 (31.9%)

18

0 (0.00%)

15 (31.9%)

15

1 (25.0%)

17 (36.2%)

18

4

47

51

African Americans’ femoral BMD status and on weight category, is summarized
in Table 4 – 10. Among the African-American participants, 8% had low femoral BMD (tscore < -1.0) values with 75% of those with low femoral BMD being found in the low
weight group (BMI ≤ 20.4 kg/m2). The remaining 25% were in the normal weight group
(20.5 ≤ BMI kg/m2 ≤ 24.4 kg/m2). Caucasian and African-American participants were
almost equally affected by low femoral BMD (t-score < -1.0) with 7.8% of Caucasians
and 8% of African Americans having low BMD. Refer to Figure 3 and Figure 4 in
Appendix F for a graphical representation of how African-Americans with low spinal and
femoral BMD compare with Caucasian participants with low spinal and femoral BMD
according to demographics/characteristics.
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Table 4 – 9
Body Mass Index Categories by Spinal Bone Mineral Density Categories of African-Americans (%)
Spinal BMD Categories
Low BMD
Normal
n (%)
n (%)

Weight Categories
Low weight: BMI ≤ 20.4 kg/m

2

2

Normal weight: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
High weight: BMI ≥ 24.5 kg/m

2

2

Total (N)

Total

8 (38.1%)

5 (17.2%)

13

10 (47.6%)

6 (20.7%)

16

3 (14.3%)

18 (62.1%)

21

21

29

50

Table 4 – 10
Body Mass Index Categories by Femoral Bone Mineral Density Categories of African-Americans (%)
Femoral BMD Categories
Low BMD
Normal
n (%)
n (%)

Weight Categories
Low weight: BMI ≤ 20.4 kg/m

2

2

Normal weight: 20.5 kg/m ≤ BMI ≤ 24.4 kg/m
High weight: BMI ≥ 24.5 kg/m

2

2

Total (N)

Total

3 (75.0%)

10 (21.7%)

13

1 (25.0%)

15 (32.6%)

16

0 (0.0%)

21 (45.7%)

21

4

46
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Survey Responses
The following questions are summarized in Table 4 – 11 according to race. Family
history of osteoporosis was more likely to occur in Caucasians in comparison to African
Americans (31.4% versus 2%, respectively). Caucasians were also more likely than
African Americans to have a family history of fracture (17.6% versus 6%, respectively).
African Americans were less likely to have been breastfed as a child in comparison to
Caucasians (22% versus 68.6%, respectively). African Americans were also less likely
to be a current smoker in comparison to Caucasians (2% versus 9.8%, respectively).
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Additionally, African- American participants were more likely to have used DepoProvera in comparison to Caucasians (18% versus 2%, respectively). Lastly,
Caucasians were more likely to meet exercise requirements in comparison to African
Americans (29.4% versus 14%, respectively).
Table 4 – 11
Percentages of Participants’ Correct Responses to Survey Items According to Race
African Americans
n = 50
2.0%
80.0%
18.0%

Items
Family history of osteoporosis
No family history of osteoporosis
Unaware of family history of osteoporosis

Caucasians
n = 51
31.4%
51.0%
17.6%

Has family history of fracture
No family history of fracture
Does not know family history of fracture

6.0%
82.0%
12.0%

17.6%
72.5%
9.8%

Breastfed as child
Not breastfed as child
Unaware of being breastfed as child

22.0%
62.0%
16.0%

68.6%
25.5%
5.9%

No milk consumption as a child
About 1 serving of milk per day as a child
About 2 servings of milk per day as a child
About 3 servings of milk per day as a child
About 4 or more servings of milk per day as a child

6.0%
18.0%
44.0%
22.0%
10.0%

9.8%
29.4%
27.5%
27.5%
5.9%

Smokes
Does not smoke

2.0%
98.0%

9.8%
90.2%

Oral contraceptive use
Depo-Provera use

62.0%
18.0%

76.5%
2.0%

*64.6%

90.2%

14.0%

29.4%

High school sports participation
Met exercise requirements
*n=48

Family history of osteoporosis was determined by self-reported information
obtained from two questions: “Was your biological mother or grandmother ever told by
a doctor that they had osteoporosis, sometimes called thin or brittle bones?” and “Did
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your biological mother or grandmother ever fracture her hip?” Participants chose from
the options of “Yes,” “No,” or “I don’t know.” It was reported by 16.8% of the participants
that their biological mother or grandmother was diagnosed with osteoporosis; whereas
65.3% reported that their biological mother or grandmother had not been diagnosed
with osteoporosis; and 17.8% reported not knowing whether or not their biological
mother or grandmother had been diagnosed with osteoporosis. Among the 16.8% who
reported that their biological mother or grandmother had been diagnosed with
osteoporosis, three participants reported that their biological mother or grandmother had
suffered a hip fracture.
Absence or presence of consumption of breast milk as a child was determined
through the question: “When you were a baby, were you breastfed?” The response
options were “Yes,” “No,” and “I don’t know.” It was reported by 45.5% of the
participants that they were breastfed as a child whereas 43.6% reported not being
breastfed as a child; and 10.9% reported not knowing whether or not they were
breastfed as a child. Data were obtained regarding childhood milk consumption through
the question, “During your childhood, approximately how many servings of milk did you
drink each day?” The answer choices were “None,” “1 serving,” “2 servings,” “3
servings,” and “4 or more servings.” It was reported by 7.9% that they consumed no
milk during their childhood; 23.8% reported having 1 serving of milk per day during
childhood; 35.6% reported having 2 servings of milk per day; 24.8% reported 3 servings
of milk per day; and 7.9% reported having 4 or more servings per day.
Current smoking habits were identified by the question, “Do you smoke?” and the
answer choices were “Yes” and “No.” Six individuals reported being current smokers
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whereas 94.1% reported being non-smokers. This means that only six participants
reported being a current smoker. Of the six who reported being a current smoker, one
was African-American and the remaining five were Caucasian.
Information regarding contraceptive use was obtained by the question, “Have you
ever taken birth control pills for any reason?” The answer choices were “Yes” and “No.”
Oral contraceptive use was reported by 69.3% of the participants whereas 30.7%
reported no oral contraceptive. Length of time on oral contraceptives was obtained from
each participant by asking, “How long all together have you taken birth control pills?”
Information regarding Depo-Provera use was obtained through the question, “Have you
ever had the Depo-Provera shot?” and the answer choices were “Yes” and “No.” DepoProvera use was reported by 9.9% of the participants.
High school sports participation was assessed by the question, “Did you
participate in sports in high school?” with the answer choices being “Yes” and “No.”
Among the 99 participants who responded to the question, 22.2% reported not
participating in high school sports while 77.8% reported participating in high school
sports.
Physical activity was assessed using a 7-day Physical Activity Recall (Dishman
and Steinhardt, 1988). This instrument records moderate and vigorous physical activity.
For the purpose of this study, the time spent engaging in moderate and vigorous
physical activities were combined. Participants were classified as meeting exercise
requirements if they engaged in at least 30 minutes of exercise, regardless of intensity,
on not less than five days of the week. This is a primary guideline set forth by the
American College of Sports Medicine and the American Heart Association for adults
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aged 18 to 65 years (Haskell et al., 2007). Only 21.8% of the participants met these
requirements. Caucasian participants were more likely to engage in the recommended
amount of exercise than African-American participants (29.4% versus 14%,
respectively). There was also a significant difference (p = 0.001) between Caucasian
and African-American participants regarding total hours of exercise with Caucasians
spending more time engaged in physical activity than African-Americans. Caucasians
reported spending an average of 7.69 hours per week engaged in physical activity in
comparison to an average of 3.36 hours per week reported by African-Americans.

Nutrition
Nutrient intake was determined from each participant’s 4-day dietary record.
Each participant’s record was entered into NDS-R. NDS-R is a dietary analysis
program developed by the Nutrition Coordinating Center at the University of Minnesota
in 1998. Three individuals who did not provide a complete 4-day recall were not
included in the analyses involving nutrient data. Table 4 – 12 shows the percentage of
participants meeting the RDA for calcium, vitamin D, iron, zinc, and magnesium. The
main nutrient of interest for the present study is calcium. The RDA of calcium for
women up until the age of 18 years is 1300 mg/day. After the age of 18 years, the RDA
is 1000 mg/day (NOF, 2008). There was a significant difference (p = 0.002) in calcium
intake between African-American and Caucasian participants. Caucasian women were
more likely than African-American women to meet the RDA for calcium (37.3% versus
16% respectively). Caucasians were also more likely than African Americans to meet
the RDA for magnesium (27.5% versus 6% respectively).
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Table 4 – 12
Percentage of African-Americans, Caucasians, and Total Sample Meeting Recommended Dietary
Allowance for Calcium, Vitamin D, Iron, Zinc, and Magnesium

Nutrients
Calcium

African
American
(n = 50)
16.0%

Caucasian
(n = 51)
37.3%

Total
(N = 101)
26.7%

Vitamin D

46.0%

56.9%

51.5%

Iron

32.0%

39.2%

35.6%

Zinc

72.0%

66.7%

69.3%

6.0%

27.5%

16.8%

Magnesium

Osteoporosis Knowledge Test Responses
Osteoporosis knowledge was assessed using the Osteoporosis Knowledge Test
(OKT) developed by Kim, Horan, Gendler, and Patel (1991). The items included in the
OKT and the percentage of correct answers for African Americans and Caucasians are
reported in Table 4 – 13. Refer to Appendix C for complete instrument. It is noteworthy
that more than 70% of Caucasian participants and more than 60% of African-American
participants did not realize that being a White woman with fair skin increases
osteoporosis risk. It is also noteworthy that 90% of African Americans and 87% of
Caucasians surveyed did not know the recommended milligrams of calcium intake for
adults. Seventy percent of African Americans and 69% of Caucasians did not know that
bone size affects osteoporosis risk. Having ovaries surgically removed was not
correctly identified as a risk factor for osteoporosis by 82% of the African- American
participants and 63% of Caucasians. More than 50% of African- American and
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Table 4 – 13
Percentage of Correct Responses on Osteoporosis Knowledge Test for Each Race and Overall

Caucasian participants (56% & 67%, respectively) did not know that brisk walking and
bicycling (52% & 57%, respectively) were better modes of exercise for preventing
osteoporosis than kitchen chores, yoga, swimming, and house cleaning. Lastly, 78% of
African Americans and 75% of Caucasians did not know that canned sardines were a
better source of calcium than watermelon and corn. Refer to Figure 5 in Appendix F for
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a graphical representation of where African-American and Caucasian participants
differed in correct responses on the Osteoporosis Knowledge Test.

Univariate Findings
ANOVAs, t-tests, and correlations were performed to examine the relationship of
each outcome variable, femoral and spinal BMD, with all of the predictor variables. The
alpha level was set at 0.05 a priori.
Independent t-tests were conducted to test mean difference in BMD for each
predictor. The alpha level was set at 0.05 a priori. The results of these tests for spinal
BMD are shown in Table 4 – 14. Based on the results from the t-test as seen in Table 4
– 14, there was no statistically significant difference between mean spinal BMD for
African Americans and Caucasians (p = 0.42). There were no significant differences in
mean spinal BMD (p > 0.05) based on any of the remaining predictors listed in Table 4 –
14 (oral contraceptive use, calcium intake, present physical activity, high school sports
participation, osteoporosis knowledge and age).
The results of the t-tests for femoral BMD are shown in Table 4 – 15. Based on
the results from Table 4 – 15, there was no statistically significant difference between
mean femoral BMD for African Americans compared to that of Caucasians. There were
no significant differences in mean femoral BMD (p > 0.05) based on any of the
remaining predictors listed in Table 4 – 15.
Mean difference in spinal BMD between African-Americans and Caucasians
were computed and tested for each BMI category using t-tests as indicated in Table 4 –
16. Based on the 95% confidence intervals (include zero) and the p-values (p>0.05)
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there was not a statistically significant difference (p = 0.47) in African Americans’ mean
spinal BMD and Caucasians’ spinal BMD for those in the low BMI category (BMI ≤ 20.4
kg/m2). There also was no statistically significant differences (p = 0.28) in mean spinal
BMD between African Americans and Caucasians in the normal BMI category.
Furthermore, there was not a statistically significant difference (p = 0.82) in African
Americans’ mean spinal BMD and Caucasians’ spinal BMD for those in the high BMI
category (BMI ≥ 24.5 kg/m2).
Table 4 – 14
Results of t-tests for Spinal Bone Mineral Density (BMD) Differences for Race, Oral Contraceptive Use,
RDA of Calcium, Physical Activity High School Sports Participation, Osteoporosis Knowledge, and Age
for Entire Sample

Categorical Variables
Race
African American
Caucasian

n

Mean
BMD

50
51

-0.57
-0.40

Oral Contraceptive Use
Yes
No

70
31

-0.57
-0.29

RDA of Calcium
Meets
Does not meet

27
74

-0.55
-0.46

Physical Activity
Meets requirement
Does not meet

22
79

-0.42
-0.50

High School Sports
Participation
Yes
No

77
22

-0.47
-0.61

Osteoporosis Knowledge
Less than 70% Correct
≥70% Correct

77
24

-0.46
-0.57

Age
18 to 24
25 to 30

93
8

-0.46
-0.80

Mean
Difference
0.16

95% Confidence
Interval
-0.24, 0.57

t-test
0.81, p = 0.42

-0.28

-0.71, 0.16

-1.26, p = 0.21

0.09

-0.37, 0.54

0.37, p = 0.71

-0.09

-0.58, 0.41

-0.35, p = 0.73

-0.14

-0.64, 0.35

-0.58, p = 0.56

0.11

-0.36, 0.59

0.47, p = 0.64

0.34

-0.41, 1.09

0.91, p = 0.37

52

Table 4 – 15
Results of t-tests for Femoral Bone Mineral Density (BMD) Differences According to Race, Oral
Contraceptive Use, RDA of Calcium, Physical Activity High School Sports Participation, Osteoporosis
Knowledge, and Age for Entire Sample

Categorical Variables
Race
African American
Caucasian

n

Mean
BMD

50
51

0.30
0.52

Oral Contraceptive Use
Yes
No

70
31

0.31
0.64

RDA of Calcium
Meets
Does not meet

27
74

0.52
0.37

Physical Activity
Meets requirement
Does not meet

22
79

0.45
0.40

77
22

0.52
0.07

Osteoporosis Knowledge
Less than 70% Correct
≥70% Correct

77
24

0.40
0.45

Age
18 to 24
25 to 30

93
8

0.43
0.11

High School Sports Participation
Yes
No

Mean
Difference
0.22

95%
Confidence
Interval
-0.17, 0.60

t-test
1.13, p=0.26

-0.33

-0.75, 0.08

-1.56, p = 0.12

-0.15

-0.59, 0.28

-0.70, p = 0.48

-0.05

-0.52, 0.42

-0.22, p= 0.83

-0.45

-0.91, 0.02

-1.90, p = 0.06

-0.05

-0.50, 0.41

-0.21, p = 0.83

0.32

-0.39, 1.04

0.89, p = 0.37

Mean difference in femoral BMD between races was computed for each BMI
category using t-tests. Results are shown in Table 4 – 17. As indicated in Table 4 – 17,
there was not a statistically significant difference (p = 0.57) in African Americans’ mean
spinal BMD and Caucasians’ spinal BMD for those in the low BMI category (BMI ≤ 20.4
kg/m2). There also was no significant difference (p = 0.39) in mean spinal BMD
between African Americans and Caucasians in the normal BMI category. Furthermore,
there was not a statistically significant difference (p = 0.28) in African Americans’ mean
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spinal BMD and Caucasians’ spinal BMD for those in the high BMI category (BMI ≥ 24.5
kg/m2).
Table 4 – 16
Mean Difference in Spinal Bone Mineral Density (BMD) Between African Americans and Caucasians for
Low, Normal, and High Body Mass Index Categories

BMI Categories
Low:
2
(BMI ≤ 20.4 kg/m )

Normal :
2
(20.5 kg/m ≥ BMI ≥
2
24.45 kg/m )
High: (BMI ≥ 24.5
2
kg/m )

n

Mean
BMD

13
18

-0.98
-0.71

Race
African
American
Caucasian

African
American
Caucasian

African
American
Caucasian

16
15

21
18

Mean
Difference
0.27

95%
Confidence
Interval
-0.47, 1.00

p
p = 0.47

0.33

-0.32, 1.05

p = 0.28

0.07

-0.57, 0.71

p = 0.82

-0.89
-0.53

-0.07
0.01

Table 4 – 17
Mean Difference in Femoral Bone Mineral Density (BMD) Between African Americans and Caucasians for
Low, Normal, and High Body Mass Index Categories

BMI Categories
Low:
2
(BMI ≤ 20.4 kg/m )

Normal :
2
(20.5 kg/m ≥ BMI
2
≥ 24.45 kg/m )

High: (BMI ≥ 24.5
2
kg/m )

Race
AfricanAmerican
Caucasian

AfricanAmerican
Caucasian

African
American
Caucasian

n

13
18

16
15

21
18

Mean
BMD

Mean
Difference

95%
Confidence
Interval

p

0.20

-0.51, 0.91

p = 0.57

0.27

-0.36, 0.90

p = 0.39

0.35

-0.30, 1.01

p = 0.28

-0.12
0.08

0.34
0.61

0.52
0.88
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ANOVAs were performed to test whether the means of femoral BMD and spinal
BMD differed according to race and BMI category. The results are shown in Tables 4 –
18 and 4 – 19. The results showed that both spinal and femoral BMD means were
significantly different for BMI categories (p = 0.001 and p = 0.01, respectively). Spinal
and femoral BMD means were not significantly different for race category or the
interaction between race and BMI category (p > 0.05).
Table 4 – 18
ANOVA Results for Comparison of Spinal Bone Mineral Density According to Race and Body Mass Index
(BMI) Category
F

p

RACE

1.45

0.23

BMI CATEGORY

7.14

0.001

RACE * BMI CATEGORY

0.21

0.81

Table 4 – 19
ANOVA Results for Comparison of Femoral Bone Mineral Density According to Race and Body Mass
Index (BMI) Category
F

p

RACE

2.07

0.15

BMI CATEGORY

4.96

0.01

RACE * BMI CATEGORY

0.06

0.94

Since, femoral and spinal BMD means were significantly different based on BMI
category, Bonferroni post-hoc tests were conducted to examine which BMI categories
had significantly different spinal and femoral BMD means. Bonferroni post-hoc results
for femoral BMD are shown in Table 4 – 20. According to the results, the mean femoral
BMD of participants with a low BMI category was significantly different from the femoral
BMD of participants with a high BMI (p = 0.01).
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Table 4 – 20
Bonferroni Comparison of Body Mass Index Categories (BMI) for Femoral Bone Mineral Density

Comparisons
Low BMI vs. Normal BMI
Low BMI vs. High BMI
Normal BMI vs. High BMI

Mean BMD
Difference
-0.47
-0.69
-0.22

Std.
Error
0.24
0.23
0.23

95% Confidence
Interval
-1.05, 0.12
-1.24, -0.13
-0.34, 0.77

p
0.16
0.01
1.00

Bonferroni post-hoc results for spinal BMD are shown in Table 4 – 21. These
results for spinal BMD showed that the mean spinal BMD of participants with a low BMI
was significantly different from the mean spinal BMD of participants with a high BMI (p =
0.001). It also showed that the mean spinal BMD of individuals with normal BMIs were
significantly different from the mean spinal BMD of individuals with high BMIs (p = 0.01).
Table 4 – 21
Bonferroni Comparison of Body Mass Index Categories (BMI) for Spinal Bone Mineral Density

Comparisons
Low BMI vs. Normal BMI
Low BMI vs. High BMI
Normal BMI vs. High BMI

Mean BMD
Difference
-0.11
-0.79
0.68

Std.
Error
0.25
0.23
0.23

95% Confidence
Interval
-0.71, 0.50
-1.36, -0.22
0.13, 1.25

p
1.00
0.003
0.01

ANOVAs were performed to test whether the femoral BMD and spinal BMD
means differ according to family history of osteoporosis categories. Results are shown
in Table 4 – 22. Spinal and femoral BMD means were not significantly different for
participants based on their family history of osteoporosis.
Table 4 – 22
ANOVA of Family History of Osteoporosis on Spinal and Femoral BMD
F

p

Family History of Osteoporosis (Spinal)

0.31

0.73

Family History of Osteoporosis (Femoral)

1.11

0.33
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Next, pairwise correlations were conducted on the continuous predictor variables:
BMI, length of time on oral contraceptives, age, and average calcium intake, with spinal
BMD and femoral BMD. The results are shown in Table 4 – 23. These results show
that BMI category (BMI) and physical activity were significantly correlated with spinal
BMD and femoral BMD. Length of time on oral contraceptives, age, and average
calcium intake were not significantly correlated with spinal BMD and femoral BMD.
Table 4 – 23
Pairwise Correlations Between Spinal and Femoral Bone Mineral Density, Body Mass Index, Length of
Time on Oral Contraceptives, Age, Physical Activity, and Average Calcium Intake

A secondary purpose of this study was to evaluate the difference in osteoporosis
knowledge among college-aged African-American women and Caucasian women.
Results of t-test are shown in Table 4 – 24. According to t-test results, osteoporosis
knowledge between African-American and Caucasian women was significantly different.
Caucasian women were more knowledgeable of osteoporosis than African-American
women.
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Table 4 – 24
Osteoporosis Knowledge Between African-American and Caucasian Women

n
Race
African American
Caucasian

Mean
Score

Mean Difference
95% Confidence Interval
0.23, 2.93

1.58
50
51

p
0.02

15.94
14.36

Multivariable Findings
Multiple linear regression was performed to determine which predictor variables
were significant in predicting femoral and spinal BMD. The multiple regression
normality assumption was tested using the Shapiro-Wilk test. The Shapiro-Wilk statistic
was non-significant (p = 0.53) which indicates that the normality assumption was not
violated. The residual plots were examined for linearity and homogeneity of variance.
The plots demonstrated a linear relationship; therefore the linearity assumption was not
violated. The standardized residuals were examined to search for outliers. None of the
standardized residuals were greater than three standard deviations from the mean;
therefore, no outliers were present. Based on these results, it was determined that the
use of multiple linear regression was appropriate.
Multiple regression was conducted to determine which predictor variables predict
spinal BMD and which of the independent variables predict femoral BMD. Multiple
regression results indicate that BMI and total hours of exercise are significant predictors
of femoral BMD as well as spinal BMD. The results from the regression analysis for
spinal BMD are presented in Table 4 – 25. Accordingly, the model for predicting spinal
BMD is as follows: Y = -2.388 + 0.073 (BMI) + 0.071 (hours of exercise).
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The final regression model is significant in predicting 14.9% (R2=0.149) of the
variance in spinal BMD (p = 0.017). Race, family history of osteoporosis, oral
contraceptive use, calcium intake, and age were not significant predictors of spinal
BMD. The model summary and the ANOVA summary table are shown below in Table 4
– 26 and Table 4 – 27, respectively.

Table 4 – 25
Multiple Regression Results for Spinal Bone Mineral Density

Table 4 – 26
Model Summary for Spinal Bone Mineral Density
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Table 4 – 27
ANOVA Summary Table for Spinal Bone Mineral Density

Table 4 – 28
Multiple Regression Results for Femoral Bone Mineral Density

The results from the regression analysis for femoral BMD are presented in Table
4 – 28. Accordingly, the model for predicting femoral BMD is as follows: Y = -1.111 +
0.078 (hours of exercise) + 0.056 (BMI). The final regression model is significant in
predicting 13.1% (R2=0.131) of the variance in femoral BMD (p = 0.010). As with spinal
BMD, race, family history of osteoporosis, oral contraceptive use, calcium intake, and
age were not significant predictors of femoral BMD. The model summary and the
ANOVA summary table are shown below in Table 4 – 29 and Table 4 – 30.
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Table 4 – 29
Model Summary for Femoral Bone Mineral Density

Table 4 – 30
ANOVA Summary Table for Femoral Bone Mineral Density

Summary of Results and Hypotheses
The results of the null hypotheses tested are discussed in the following
paragraphs. HO1 stated that African-American women’s bone mineral density level
would not be significantly different from Caucasian women’s bone mineral density
among low, normal, and high weight categories groups. ANOVA results showed that
there was no significant difference in the mean spinal and femoral BMD (p = 0.23 and
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p = 0.15, respectively) between African-American and Caucasian women. Furthermore,
there was no significant difference in the mean spinal and femoral BMD of AfricanAmerican and Caucasian women based on the interaction between race and weight
category (p = 0.81 and p = 0.94, respectively). Therefore there was no significant
difference between the mean spinal and femoral BMDs of African-American and
Caucasian women in the low-weight category; there was no significant difference
between the mean spinal and femoral BMDs of African-American and Caucasian
women in the normal-weight category; and there was no significant difference between
the mean spinal and femoral BMDs of African-American and Caucasian women in the
high-weight category. Therefore, HO1 failed to be rejected.
HO2 stated that women with high BMIs (high weight) would not have significantly
different bone mineral density than women with low BMIs (low weight) regardless of
race. ANOVA results showed that both spinal and femoral BMDs were significantly
different (p = 0.001 and p = 0.01, respectively) across BMIs. Bonferroni post-hoc
results for femoral BMD showed that the femoral BMD of participants with a low BMI
was significantly different from the femoral BMD of participants with a high BMI
(p = 0.01). Bonferroni post-hoc results for spinal BMD showed that the spinal BMD of
participants with a low BMI was significantly different from the spinal BMD of
participants with a high BMI (p = 0.003). It also showed that the lumbar spine BMD of
individuals with a normal BMI was significantly different from spinal BMD of individuals
with a high BMI (p = 0.01). Therefore, HO2 was rejected.
HO3 stated that women who have inadequate intake of calcium would not have a
significantly different BMD than women who have an adequate intake of calcium. The
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results of t-test analyses also showed that the mean spinal and femoral BMDs of those
who had an adequate intake of calcium were not significantly different from those who
had an inadequate intake of calcium (p = 0.71 and p = 0.48, respectively). Therefore,
HO3 failed to be rejected.
HO4 stated that BMD would not be significantly different in women who currently
engage in regular physical activity in comparison to women who do not engage in
regular physical activity regardless of ethnicity. Results of t-test analyses also showed
that those who currently engaged in an adequate amount of physical activity did not
have significantly different spinal or femoral BMDs from those who did not currently
engage in adequate amounts of physical activity (p = 0.73 and p = 0.83, respectively).
Therefore, HO4 failed to be rejected.
HO5 stated that women who participated in high school sports would not have
significantly different BMD values from women who did not participate in sports during
high school regardless of ethnicity. Results of t-test analyses showed that those who
participated in high school sports did not have significantly different spinal or femoral
BMDs from those who did not participate in sports during high school (p = 0.56 and
p = 0.60, respectively). Therefore, HO5 failed to be rejected.
HO6 stated that length of time on oral contraceptives would not be significantly
related BMD. Pairwise correlations showed that length of time on oral contraceptive
was not significantly related to spinal BMD (p = 0.42) or femoral BMD (p = 0.35).
Analyses by t-test also showed that those who took oral contraceptives did not have
significantly different spinal or femoral BMD (p = 0.21 and p = 0.12, respectively) from
those who did not take oral contraceptives. Therefore, HO6 failed to be rejected.
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HO7 stated that BMD values would not be significantly different in women who are
more knowledgeable of osteoporosis in comparison to those who are less
knowledgeable. Results of t-test analyses showed that those who were more
knowledgeable about osteoporosis did not have significantly different spinal or femoral
BMDs from those who were less knowledgeable about osteoporosis (p = 0.64 and
p = 0.83, respectively). Therefore, HO7 failed to be rejected.
HO8 stated that BMD values would not be significantly different between African
American and Caucasian women. Analyses from t-test also showed that AfricanAmericans’ mean spinal and femoral BMD was not significantly different from
Caucasians’ mean spinal and femoral BMD (p = 0.42 and p = 0.26, respectively).
Therefore, HO8 failed to be rejected.
The secondary purpose of this study is to examine differences in osteoporosis
knowledge between African-American and Caucasian participants. According to t-test
results, there is a significant difference in osteoporosis knowledge between AfricanAmerican and Caucasian participants (p = 0.02). Caucasians are more knowledgeable
about osteoporosis than African-Americans.
The research question for this study was: What variables account for the
variance in BMD among African-American and Caucasian college-aged women?
Results of multiple linear regression showed that after including the predictor variables
age, physical activity, race, calcium intake, contraceptive use, family history of
osteoporosis, and BMI in the regression equation, only body mass index and total
exercise significantly predicted spinal BMD (p = 0.001 and p = 0.017, respectively).
Body mass index and total exercise also significantly predicted femoral BMD (p = 0.010

64

and p = 0.007, respectively). The final regression models were significant in predicting
13.1% (R2=0.131) of the variance in femoral BMD (p = 0.010) and 14.9% (R2=0.149) of
the variance in spinal BMD (p = 0.017).
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Chapter V
Discussion
The primary purpose of this research was to explain the variance in BMD in
African-American and Caucasian college-aged women. A secondary purpose was to
evaluate the differences in osteoporosis knowledge among college-aged AfricanAmerican and Caucasian women. This chapter is divided into the following sections:
(1) discussion of results, (2) additional findings, (3) recommendations, and (4) future
research.
According to K. Khan et al. (2004), approximately 15% of premenopausal women
have low bone mineral density. In this study of premenopausal women, 38.6% had low
spinal BMD; and 7.9% had low femoral BMD. Although some premenopausal women
have low bone mineral density, the U.S. Preventive Services Task Force (as cited by
USDHHS, 2004) does not recommend routine bone density testing for women until the
age of 65. The Task Force also recommends testing starting at the age of 60 for
women who are at high risk for osteoporosis having a body weight less than 70 kg or
having a lack of hormone replacement therapy.
Given that it is possible for premenopausal women to have low bone mineral
density, the researcher sought to identify factors that are responsible for determining
BMD in African-American and Caucasian premenopausal women. The predictor
variables included in the model were age, physical activity, race, calcium intake,
contraceptive use, family history of osteoporosis and BMI. These variables are risk
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factors for low bone mineral density. The outcome variables, non-dominant femoral
BMD and spinal BMD, were measured using a Hologic Delphi-W DEXA machine.

Discussion of Results
Finding no racial differences across BMI groups was an unprecedented finding
because numerous studies show that African-American women consistently have higher
BMDs when compared to their Caucasian counterparts ((Barrett-Connor et al., 2005;
USDHHS, 2004; Finkelstein, 2002; NIH, 2001; Ettinger et al., 1997). Due to previous
research findings, one would expect that African-American women would consistently
have higher BMDs than Caucasian women across each BMI category. This, however,
is not what the present study found. It is possible that the higher prevalence of past and
present use of Depo-Provera among African-American participants eliminated the racial
differences that would typically be seen in this age group. In the present study, 18% of
African-Americans reported past or current Depo-Provera use in comparison to 2% of
Caucasian participants. Depo-Provera, a contraceptive which is injected
intramuscularly, can cause a decline in femoral and spinal BMD (Walsh et al., 2008;
Clark et al., 2004).
A number of studies show that weight status affects BMD (Coin et al., 2000;
Rollins, Imrhan, Czajka-Narins, and Nichols, 2003; Young et al., 2001; and Wang et al.,
2005). In the present study 43.6% of individuals who were classified as having a low
BMI also had low spinal BMD; and 75% of those who had a low BMI also had low
femoral BMD. As a matter of fact, being thin and/or having a small frame is listed as
one of the risk factors for low bone mass (Amonkar and Mody, 2002; NOF, 2008),
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meaning that a larger frame or higher weight would be associated with a higher bone
density.
The present study found no significant difference between the BMDs of women
who had an inadequate intake of calcium and those who had an adequate intake of
calcium is a very interesting finding. This is interesting because, historically, low
calcium intake has been listed as a risk factor for osteoporosis (NOF, 2008).
Additionally, studies show that calcium intake plays a significant role in determining
bone density (Harris et al., 2003; Gourlay and Brown, 2004; Heaney, 2001; and Prince
et al., 2006). Other studies, however, show that calcium intake is not important in
determining BMD (Michaelsson, Melhus, Belloco, and Wolk, 2003; and Wallace and
Ballard, 2002). It is possible that no significant differences were seen between the
spinal and femoral BMDs of women who had an adequate intake of calcium versus
women who had an inadequate intake of calcium because this study only examined
current calcium intake and not calcium intake over the life span.
Bainbridge, Sowers, Lin, and Harlow (2004) examined risk factors for low BMD in
Caucasian women ages 22 to 44. They found that current physical activity is not related
to BMD. When participants in the present study were categorized into two groups-those who met the physical activity requirements and those who did not--t-test results
show no significant difference in spinal or femoral BMDs between the two groups.
However, when spinal and femoral BMD were regressed on hours of current physical
activity, it was a significant predictor of both spinal and femoral BMD. This finding is
consistent with Ford et al. (2004), whose study included 157 women, aged 18 to 39.
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They found that current physical activity was significantly associated with spinal BMD
(p = 0.004).
The American College of Sports Medicine and The American Heart Association
recommends at least 30 minutes of exercise on not less than five days of the week for
adults aged 18 to 65 years (Haskell et al., 2007). Only 21.8% of the participants in this
study met these requirements. Furthermore, 33.7% of this sample reported no physical
activity. The latter finding is consistent with the findings of Wallace (2002), who found
no physical activity reported in 30% of the subjects in a similar age group to that of the
present study. Total hours of exercise were significantly different between Caucasians
and African-Americans. Caucasians reported spending an average of 7.69 hours per
week engaged in physical activity in comparison to an average of 3.36 hours per week
reported by African-Americans. Caucasians were also more likely to meet exercise
requirements in comparison to African-Americans (29.4% versus 14%). The lack of
physical activity is a possible reason why low spinal BMD was so prevalent in this
sample.
Asking participants about their high school sports participation was used to
determine physical activity during teenage years. The typical age of a high school
student is 15 to 18 years. Physical activity during the teenage years is deemed
important due to the fact that the typical female accumulates 40 to 60 percent of their
bone mass during these years (Lloyd et al., 2000). Therefore, physical activity during
this crucial time can have an effect on BMD. Studies have found high school sports
participation to be a factor affecting BMD among this age group (Ford et al., 2004;
Bainbridge et al., 2004). For example, Ford et al. (2004) found that women between the
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ages of 18 and 39, who did not participate in high school sports, were seven times more
likely to have low BMD in comparison to those who were involved in sports during high
school. High school sports participation was assessed by the question, “Did you
participate in sports in high school?” with the answer choices being “Yes” and “No.” It is
possible that the present study did not find significant differences in BMD between those
who participated in high school sports and those who did not as did previous because of
racial differences in the samples. Both Ford et al. (2004) and Bainbridge et al. (2004)
had samples that were predominantly Caucasian, whereas the present study had an
even distribution of African-American and Caucasian women.
Data, in regards to the affect that oral contraceptive use has on BMD, is
equivocal. There are some studies that show that oral contraceptive use has a
beneficial effect on BMD in a similar age group to the present study (Pasco et al., 2000;
Kleerekoper, Brienza, Schultz, and Johnson, 1991); while other studies show that oral
contraceptive use has a negative effect on BMD (Prior et al., 2001; Shoepe and Snow,
2005; Egan, Reilly, Giacomoni, Redmond, and Turner, 2006). Additionally, studies
show that oral contraceptives either have no effect on BMD or that the results of the
effect of oral contraceptives on BMD are inconclusive (Reed et al., 2003; Cobb et al.,
2007). The average length of time on oral contraceptives for participants in this study
was 2.5 years (SD ±2.35 years). It is possible that an effect on BMD from oral
contraceptive use was not seen in this study due to participants not being on oral
contraceptives long enough to see an effect. It is believed that a number of years of
oral contraceptive use in premenopausal women are needed before seeing a significant
effect on BMD (Kuohung, Borgatta, and Stubblefield, 2000). Kleerekoper et al. (1991)
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found that the greatest protection against low BMD was seen in pre- and
postmenopausal women who had taken oral contraceptives for 10 or more years.
A little over half of the participants (56.4%) answered approximately 60% of
osteoporosis knowledge questions correctly. These results are similar to that of
Anderson, Auld, and Schilitz (1996) who assessed the osteoporosis knowledge of
women in a similar age group (aged 18 to 35 years). In the present study, over 90% of
the participants knew that having a diet low in dairy products and not engaging in
regular physical activity put them at increased risk for osteoporosis. These findings are
similar to that of other studies in a similar age group to the present study (Ford, Bass,
and Keathley, 2007; Kasper, Peterson, and Allegrante, 2001). Unfortunately,
knowledge alone is often not enough to cause a behavior change (Wallace, 2002).
Furthermore, studies show that osteoporosis prevention behaviors in women are not
influenced by their osteoporosis knowledge (Terrio and Auld, 2002; Kasper, Peterson,
and Allegrante, 2001). This can possibly explain why no significant difference in BMD
as a result of more osteoporosis knowledge versus lack of knowledge was observed in
the present study. Although participants were knowledgeable about osteoporosis that
did not translate to them engaging is osteoporosis-preventative behaviors.

Other Findings
Only 5.9% of this sample reported being a current smoker. Furthermore,
Caucasian women were more likely to be a current smoker in comparison to African
American women (9.8% versus 2%). The percentage of current smokers in the present
study was low compared to 22.5% smoking rate among women in Mississippi ages 18
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years and older and the 28.8% smoking rate among individuals in Mississippi between
the ages of 18 and 35 (MMWR, 2006). Therefore, our sample may have been drawn
from a healthier population.
Family history of osteoporosis was determined by self-reported information
obtained from two questions: “Was your biological mother or grandmother ever told by
a doctor that they had osteoporosis, sometimes called thin or brittle bones?” and “Did
your biological mother or grandmother ever fracture her hip?” Participants chose from
the options of “Yes,” “No,” or “I don’t know.” It was reported by one African-American
participant that her biological mother or grandmother was diagnosed with osteoporosis;
whereas 17 (31.4%) Caucasian participants reported that their biological mother or
grandmother had been diagnosed with osteoporosis. Although only one AfricanAmerican participant reported having a family history of osteoporosis, three AfricanAmerican participants reported having a family history of fracture. There are three
possible reasons as to why the number of African-Americans reporting a family history
of hip fractures is higher than the number of African-Americans reporting a family history
of osteoporosis. One reason could be because all fractures are not necessarily
osteoporotic fractures; so the hip fractures that occurred could have been due to factors
other than osteoporosis. Secondly, it is possible that the family member who suffered
the fracture was unaware of her osteoporotic-status. Thirdly, 18% of African-American
participants reported not knowing their family history of osteoporosis. Therefore, it is
possible that the participant did not know the osteoporotic-status of the family member
who suffered the hip fracture.
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Absence or presence of consumption of breast milk as a child was determined
through the question: “When you were a baby, were you breastfed?” The response
options were “Yes,” “No,” and “I don’t know.” It was reported by 45.5% of the
participants that they were breastfed as a child whereas 43.6% reported not being
breastfed as a child; and 10.9% reported not knowing whether or not they were
breastfed as a child. Of the 45.5% who reported being breastfed as a child, only 11
were African-American whereas 35 were Caucasian. It is possible that the absence of
being breastfed as an infant contributed to the presence of low BMD in this sample.
Jones, Riley, and Dwyer (2000) found that BMD was higher in 8-year-old children who
were breastfed longer than 3 months in comparison to the formula-fed children.
Data were obtained regarding childhood milk consumption through the question,
“During your childhood, approximately how many servings of milk did you drink each
day?” The answer choices were “None,” “1 serving,” “2 servings,” “3 servings,” and “4
or more servings.” It was reported by 7.9% that they consumed no milk during their
childhood; and 7.9% reported having 4 or more servings per day. For the purposes of
this study, one serving of milk is equivalent to one cup; therefore, those who reported
having four or more servings of milk per day were in actuality reporting that they
consumed four or more cups of milk per day. There are 283.8 mg (1200mg/L) of
calcium per cup of milk (Zhao, Martin, and Weaver, 2005). If milk was their only source
of calcium during childhood, this means that only 8 participants consumed the
recommended amounts of calcium during childhood. This finding is important because
Kalkwarf, Khoury, and Lanphear (2003) found that women between the ages of 20 and
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49 years who had a low intake of milk during childhood and adolescence also have a
lower bone mass in adulthood.

Recommendations
It is clear from the number of participants in the study who are affected by low
BMD that programs need to be established to encourage young women to engage in
behaviors that will maximize their bone densities. According to A. Khan (2006),
premenopausal women should be encouraged to modify their lifestyles to improve their
BMD. It has been shown that physical activity, particularly weight-bearing exercises,
help to improve BMD. In this study, however, only 21.8% of the participants got the
recommended amount of physical activity. Furthermore, in this study Caucasians were
more likely than African-Americans to meet the exercise requirements. Since physical
activity was significant in predicting bone mineral density in this study, programs that
specifically target increasing physical activity among young women should be
established. Additionally, programs that target increasing the amount of physical
activity among African-Americans should be established.
Although Caucasian women were more knowledgeable than African-American
women regarding osteoporosis, overall, osteoporosis knowledge was lacking in this
sample. A little over half of the participants (56.4%) answered approximately 60% of
osteoporosis knowledge questions correctly. Although most participants were aware
that lack of dairy products and lack of exercise put them at risk of osteoporosis, they
were less aware of the specific types of foods that provide calcium and the specific
types of exercises that improve bone health. Therefore, programs need to be put in

74

place to not only increase knowledge about osteoporosis, but also to encourage
implementation of bone building behaviors.

Future Research
In this study, BMI was a significant predictor of both spinal and femoral BMD.
Furthermore, participants in the low BMI category had significantly different mean
femoral BMDs than individuals in the high BMI category; and participants in the low and
normal BMI categories had significantly different mean spinal BMDs than individuals in
the high BMI category. Studies, however, have shown that the proportion of lean mass
to fat mass has an effect on BMD (Wang et al., 2005; Young et al., 2001). One of the
limitations of the present study is not distinguishing between fat mass and lean mass,
although these measurements were taken. BMI was used rather than fat and lean
mass to give physicians and the general public a more convenient way of determining
risk for low BMD. Therefore, future research should look more in-depth at the fat mass
and lean mass of the individuals in this study to determine their contribution to the
differences in BMD.
After including variables that affect bone mineral, only two, weight and physical
activity, of the seven predictors were significant in predicting spinal and femoral BMD.
Furthermore, these two significant predictors only accounted for 14.9% and 13.1% of
the variance in spinal and femoral BMD, respectively. It is possible that genetics
accounts for, in part, the remaining unexplained variance. According to Koller et al.
(2000), up to 80% of the differences seen in peak BMD can be attributed to genetic
factors.
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Hormones, such as estrogen, possibly played a part in the remaining
unexplained variance. Early menarche has been shown to result in higher BMD in
premenopausal women just as late menarche has been shown to result in lower BMD
and increased risk of fracture in postmenopausal women (Chevalley, Bonjour, Ferrari,
and Rizzoli, 2008). These findings are due to the differences in duration of exposure to
estrogen (Chevalley, Bonjour, Ferrari, and Rizzoli, 2008). Data regarding age at
menarche was collected for the current study but was not included as one of the
predictor variables for the regression model. Including an additional variable would
have required at least an additional 10 participants. Therefore, this variable was not
included due to budgetary restraints. A future study can examine the age at menarche
for participants in the current sample to determine what affect, if any, this variable had
on BMD values.
Another avenue for future research could include the replication of the current
study in an older age group. Racial differences were not observed in this study. It is
possible that racial differences in bone mineral density occur at a later age than that
used in the current study. This seems plausible seeing that women in the current age
group have not reached peak BMD.
The restrictions in this sample cannot be discounted as attributing to the lack of a
substantial amount of variance in BMD being found. Since this sample was restricted
regarding age and factors that place women at apparent risk for low BMD, the amount
of variability was reduced. Therefore, it is difficult for the current study to account for a
substantial amount of variance due to the research design limiting the variability of the
sample.
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Conclusions:
Contrary to what was hypothesized, race was not a significant predictor of spinal
or femoral BMD. Therefore, it is important for both African-American and Caucasian
women alike to engage in osteoporosis-preventive behaviors. If women between the
ages of 18 and 30 are made aware of their low-BMD status, they can begin bonebuilding activities before they reach peak bone mass. This provides an opportunity to
decrease risk for osteoporosis and related fractures later in life. Women between the
ages of 18 and 30 can also be encouraged to maintain a healthy body weight and be
more physically active to potentially increase their spinal and femoral BMD.
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INITIAL PHONE CONTACT WITH POTENTIAL SUBJECT
S TUDY: A Comparison of Bone Mineral Density in African American and Caucasian College
Women
INVESTIGATO RS : ANDREA JO HNSON, MS & M. ALLISON FO RD, P H.D

Part 1: Subject Information (Part of PI’s confidential records – do not make hard copies of part 1)

Name of investigator or study personnel: _________________________________________________
Date of phone call: ______/______/______

Time of phone call: ______:______

How did the subject hear about the study (circle)?
1. Flyer
2. Class visit
3. Other – Please specify _____________________________________________________
Verbal Informed Consent Process
1. Verbal informed consent process completed (i.e. phone script on p. 2) (circle):
2. Verbal consent obtained (circle):

YES - NO

YES - NO

Time: ______:______

3. If answer to question 2 is NO, discontinue phone conversation with subject, otherwise proceed with question
no. 4
4. If answer to question 2 is YES, then record following information from the subject:
a. Subject’s First Name:

______________________________________

b. Age: _________
c.

Race:________________

d. Assign subject ID ____________________________
Part 2: Phone Script
Thank you for calling to find out more about our research study. My name is {staff name}, and I am a researcher at
the University of Mississippi. The main purpose of this research study is to investigate bone mineral density among
African American and Caucasian college age females. A secondary purpose of this study is to test osteoporosis
knowledge among African American and Caucasian college age women. The following information will be destroyed
if you choose not to participate. At any point during this conversation if you answer “NO” to a question and would like
to discontinue, no more questions will be asked and you will be deemed ineligible to participate.

98

If you decide to participate in the study, we will ask you to come in for 2 visits (~ 1 hour each). During your 1st
visit, you will complete an osteoporosis risk factor assessment, a 7-day physical activity recall instrument,
and an osteoporosis knowledge questionnaire. You also will be instructed on how to record your food
intake for 2 weekdays and 2 weekend days. On your 2 nd visit, you will receive a DEXA scan (similar to
an x-ray) to measure bone mineral density. You will also provide me with your 4-day food record and
verify the information contained in your food record. Do you think you might be interested in participating in
that study?
{If answer is “NO”, discontinue conversation}: Thank you very much for calling.
{If answer is “yes”, proceed}: O.K.

Before enrolling people in this study, we need to determine if you are eligible. And so what I would like to do now is
ask you a few questions about your current and past health condition. Also, I would like to let you know that the
information that I receive from you by phone and reveals your name or identity will be strictly confidential and will be
kept securely. The purpose of these questions is only to determine whether you are eligible for our study. Remember
that your participation is voluntary.
Do I have your permission to ask you these questions and record your answers?
{If answer is “NO”, discontinue conversation}: Thank you very much for calling.
{Record answer and time in part 1 / no.2}
{If answer is “YES”, proceed}: O.K.
{Record answer and time in part 1 / no.2 and proceed with part 1 / no. 4 and part 3)
Part 3: Eligibility Criteria / Phone screening conducted if answer to question no. 2 in part 1 is YES

•

Date of phone screening:

______/______/______

•

What is your height___________inches

•

What is your weight___________lbs

BMI TO BE CALCULATED HERE FOR EXCLUSION CRITERIA:
Formula: weight (lb) / [height (in)]2 x 703
Calculation: [weight (lb) / height (in) / height (in)] x 703
Calculate BMI by dividing weight in pounds (lbs) by height in inches (in) squared and multiplying by a conversion
factor of 703.
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Example: Weight = 150 lbs, Height = 5’5” (65")
Calculation: [150 ÷ (65)2] x 703 = 24.96
BMI:______________________
**NOTE: Must be less than 18.5 or between 25 and 30 in order to continue if not---Thank you for
showing interest in our research study. At this time, you are not eligible for our study.
•

Ask the participant the following questions:
 If any participant answers YES to any of these questions (UNLESS NOTED ON THE
QUESTION), they will not be eligible for this study.
o

Have you ever been diagnosed wi th Cushings Disease?

YES

-

NO

o

Have you ever been diagnosed wi th Celiac Disease?

YES

-

NO

o

Have you ever or do you currently smoke cigarettes?

YES

-

NO



If yes-> How many cigarettes per day do you smoke
__________
(NOTE: There a typically 20 cigs per pack)
(NOTE WE WILL NOT EXCLUDE ALL SMOKERS JUST THOSE WHO SMOKE MORE THAN
A HALF PACK OF CIGARETTES PER DAY)

o

Is your age between 18 and 30 years
NOTE: PARTICIPANT MUST answer YES

YES

-

NO

o

Have you ever been diagnosed wi th anorexia or bulimia

YES

-

NO

o

Have you ever taken synthetic glucocortic oids-als o called
steroids including cortis one, prednisone?

YES

-

NO

YES

-

NO

Anti-convuls ants

YES

-

NO

Thyroid hormone

YES

-

NO

Antacids that contain aluminum

YES

-

NO

Methotrexate -- used to treat a variety of cancers,
immune disorders, and resistant arthritic conditions

YES

-

NO


o

If yes-> have you taken these for longer
Than 6 weeks

Have you ever taken any of the following medications?

Cyclosporine A -- used in organ transplantation and for the
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•

treatment of some diseases of the immune system

YES

-

NO

Gonadotropin Releasing Hormone (GnRH) Analo gues –
used in the long-term treatment of Endometriosis

YES

-

NO

Heparin -- used to prevent blood clotting

YES

-

NO

Cholestyramine -- used to control blood cholesterol levels

YES

-

NO

Depo-Provera

YES

-

NO

YES

-

NO

Do you have any questions for me?
If yes, summarize subject’s concerns/questions:

_________________________________________________________________________________________
_________________________________________________________________________________________

•

Subject’s questions and concerns were answered (circle):

YES

-

NO

•

Based on phone screening, is subject eligible to participate in the study?
If YES, proceed with part 4. If NO, please destroy all subject information.

YES

-

NO

•

As determined through this phone screening, you are eligible to participate, would you be interested in
participating:
YES
NO

•

Now that we have determined you are eligible to participate, I would like to record your contact information to
contact you for testing purposes and scheduling:

Subject’s Phone Number: ______________________________________
Alternate Phone Number: ______________________________________
Subject’s Email Address: ______________________________________
*********END OF Part 3: Eligibility criteria / Phone screening*********
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Part 4: Subject Availability for Testing

Time

MON

TUES

WED

THURS

FRI

Morning
Afternoon

Other Information provided to subject:
• For testing, please wear
o Pants

o Comfortable clothing that does not contain metal objects such as buttons and zippers or
under wire bras.
• You will be asked to consent to a urine pregnancy test (under 55 and/or have had a hysterectomy)
• Directions if needed
• Schedule time or will be contacted to schedule a time
Additional notes: _____________________________________________________________________________

102

Appendix B
Osteoporosis Knowledge Test
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Appendix C
7-Day Physical Activity Recall
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Appendix D
Demographics Questionnaire
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Please answer to the best of your knowledge.

1. Was your biological mother or grandmother ever told by a doctor they had
osteoporosis, sometimes called thin or brittle bones?
a. Yes
b. No
c. I don’t know
1a. Has a doctor ever told you that you have osteoporosis, sometimes
called thin or brittle bones?
a. Yes
b. No
1b. If your doctor has told you that you have osteoporosis, have you
ever taken any medication other than calcium supplements for this
disease?
a. Yes
b. No
c. I don’t know
2. Did your biological mother or grandmother ever fracture her hip?
a. Yes
b. No
c. I don’t know
3. When you were a baby, were you breastfed?
a. Yes
b. No
c. I don’t know
4. Have you ever been on a high protein diet (Atkins, South Beach, etc)?
a. Yes
b. No (if No, skip to #6)
5. How long have you been on this diet (or how long were you on this diet)?
a.
b.
c.
d.
e.

more than 1 year
10-12 months
7-9 months
4-6 months
1-3 months
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6. During your childhood, approximately how many servings of milk did you
drink each day?
a.
b.
c.
d.
e.

None (0 servings)
1 serving each day
2 servings each day
3 servings each day
4 or more servings each day

7. In general, do you take the stairs or the elevator?
a. Stairs
b. Elevator
The next questions ask about your background.
8. When is your birthday? (MM/DD/YY)

9. Which of the following best describes your ethnic group?
a.
b.
c.
d.
e.
f.
g.

1=
2=
3=
4=
5=
6=
7=

Non-Hispanic White
Non-Hispanic African American
Asian American or Asian
American Indian or Alaska Native
Native Hawaiian/Pacific Islander
Hispanic—country of origin___________________
Other

10. Does anyone who lives with you smoke cigarettes in the home?
a. Yes
b. No (if No, skip to #12)
11. Total number of persons who smoke cigarettes in the home.
a.
b.
c.
d.
e.

0
1
2
3
4+

12. Do you smoke?
a. Yes
b. No (if No, skip to #14)
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13. If you have ever smoked cigarettes, how long did you smoke?
a.
b.
c.
d.
e.
f.

I have never smoked cigarettes
less than 1 year
less than 3 years
less than 5 years
less than 10 years
greater than 10 years

14. How many alcoholic beverages do you generally consume in a setting?
a.
b.
c.
d.
e.

0
1
2
3
4+

15. Have you had a period in the last 12 months?
a. Yes
b. No
16. Have you ever been amenorrheic (lost your menstrual cycle for any reason,
other than pregnancy for longer than 3 months)?
a. Yes
b. No

17. Have you ever taken or used estrogen or female hormones in any form (i.e.
pills, vaginal cream, suppositories, injections or skin patches?
a. Yes
b. No
18. How old were you when you first took or used the estrogen or female
hormones? _____years
19. Have you ever taken birth control pills for any reason?
a. Yes
b. No
20. How long altogether have you or did you take birth control pills? _________
21. Have you ever had the Depo-Provera shot?
a. Yes
b. No (if No, skip to #24)
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22. If you are currently taking, how long have you been taking the DepoProvera shot? _______
23. If you are currently not taking the Depo-Provera shot, but have in the past,
how long did you consistently take it? ________________
24. How many live births have you had?
a.
b.
c.
d.
e.
f.
g.
h.

I have never had a live birth (if never, skip to #29)
1 live birth
2 live births
3 live births
4 live births
5 live births
6 live births
More than 6 live births

25. If you have had a live birth, how many did you have before age 30 and after age
30?
_____ before age 30
_____ after age 30
26. Approximately how much weight did you gain with each live birth
pregnancy?
1st pregnancy ________lbs

4th pregnancy ________lbs

2nd pregnancy ________lbs

5th pregnancy ________lbs

3rd pregnancy ________lbs

6th pregnancy ________lbs

27. Did you breastfeed any of your children?

Yes

No

28. If yes, how many of your children have you breastfed? _________
29. Education: _______years (total # years in college)
30. College Major: ____________________________________________
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Figure 1: Comparison of Low and Normal Femoral Bone Mineral Density on Mean Body Mass Index,
Total Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral Contraceptives
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Figure 2: Comparison of Low and Normal Spinal Bone Mineral Density on Mean Body Mass Index, Total
Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral Contraceptives
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Figure 3: Comparison of Caucasians and African – Americans with Low Femoral Bone Mineral Density
on Mean Body Mass Index, Total Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral
Contraceptives
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Figure 4: Comparison of Caucasians and African – Americans with Low Spinal Bone Mineral Density on
Mean Body Mass Index, Total Hours of Exercise, Total Grams of Calcium, and Length of Time on Oral
Contraceptives
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Figure 5: Comparison of Percentages of Correct Answers Between African-Americans and Caucasians
on Osteoporosis Knowledge Test. Note: Numbers around the graph corresponds to each question on the
Osteoporosis Knowledge Test.
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